US20020022880A1 - Device and method for restructuring heart chamber geometry - Google Patents

Device and method for restructuring heart chamber geometry Download PDF

Info

Publication number
US20020022880A1
US20020022880A1 US09/834,339 US83433901A US2002022880A1 US 20020022880 A1 US20020022880 A1 US 20020022880A1 US 83433901 A US83433901 A US 83433901A US 2002022880 A1 US2002022880 A1 US 2002022880A1
Authority
US
United States
Prior art keywords
assembly
heart
bands
collar
connector bar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/834,339
Inventor
David Melvin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24327080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20020022880(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to US09/834,339 priority Critical patent/US20020022880A1/en
Publication of US20020022880A1 publication Critical patent/US20020022880A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2478Passive devices for improving the function of the heart muscle, i.e. devices for reshaping the external surface of the heart, e.g. bags, strips or bands
    • A61F2/2481Devices outside the heart wall, e.g. bags, strips or bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10Location thereof with respect to the patient's body
    • A61M60/122Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
    • A61M60/126Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
    • A61M60/148Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10Location thereof with respect to the patient's body
    • A61M60/122Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
    • A61M60/165Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/20Type thereof
    • A61M60/289Devices for mechanical circulatory actuation assisting the residual heart function by means mechanically acting upon the patient's native heart or blood vessel structure, e.g. direct cardiac compression [DCC] devices

Definitions

  • the present invention relates to a device and method for treating cardiomyopathies and/or enlarged hearts and more specifically, a device and method for decreasing a heart chamber's wall tension.
  • the natural heart and specifically, the cardiac muscle tissue of the natural heart (e.g., myocardium) can fail for various reasons to a point where the natural heart cannot provide sufficient circulation of blood for a body so that life can be maintained. More specifically, the heart and its chambers can become enlarged for a variety of causes and/or reasons, including viral disease, idiopathic disease, valvular disease (mitral, aortic and/or both), ischemic disease,
  • a problem with an untreated dilated ventricle is that there is a significant increase in wall tension and/or stress, both during the diastolic filling, and during the systolic contraction.
  • the adaption of muscle hypertrophy (e.g. thickening) in the ventricular dilation maintain a fairly constant wall tension for systolic constriction.
  • the ongoing dilation is greater than the hypertrophy, and as a result, rising wall tension is required for systolic contraction. This is believed to result in further muscle damage.
  • An alternative procedure is to transplant a heart from another human or animal into a patient.
  • the transplant procedure requires removing an existing organ (i.e., the natural heart) for substitution with another organ (i.e., another natural heart) from another human, or potentially, from an animal.
  • the substitute organ Before replacing an existing organ with another, the substitute organ must be “matched” to the recipient, which can be, at best, difficult and time consuming to accomplish.
  • the transplanted organ matches the recipient a risk exists that the recipient's body will reject the transplanted organ and attack it as a foreign object.
  • the number of potential donor hearts is far less than the number of patients in need of a transplant. Although use of animal hearts would lessen the problem with fewer donors than recipients, there is an enhanced concern with rejection of the animal heart.
  • bypass systems of this type are complex and large, and, as such, are limited to short term use in an operating room during surgery, or to maintaining the circulation of a patient while awaiting receipt of a transplant heart.
  • the size and complexity effectively prohibit use of bypass systems as a long term solution, as they are rarely even portable devices.
  • long term use of these systems can damage the blood cells and blood borne products, resulting in post surgical complications such as bleeding, thromboembolism function, and increased risk of infection.
  • Medicines have been used to assist in treating cardiomyopathies.
  • Some inotropic agents can stimulate cardiac work.
  • digoxin can increase the contractibility of the heart, and thereby enhances emptying of the chambers during systolic pumping.
  • Medicines such as diuretics or vasodilators attempt to reduce or decrease the heart's workload.
  • indirect vasodilators such as angiotensin-converting enzyme inhibitors (e.g., enalopril), can help reduce the tendency of the heart to dilate under the increased diastolic pressure experienced when the contractibility of the heart muscle decreases.
  • Many of these medicines have side effects, such as excessive lowering of blood pressure, which make them undesirable for long term therapy.
  • Another object of the present invention is to provide a device and method for treating cardiomyopathies that supports and maintains the competence of the heart valves so that the heart valves can function as intended.
  • Still another object of the present invention is to provide a device and method that increases the pumping effectiveness of the heart.
  • Yet another object of the present invention is to provide a device and method for treating cardiomyopathies on a long term basis.
  • Still a further object of the present invention is to provide a device and method for treating dilated cardiomyopathies that directly reduce the effective radius of a chamber of a heart in systole as well as in diastole.
  • a geometric reconfiguration assembly for the natural heart having a collar configured for surrounding the natural heart.
  • the collar can include a plurality of bands, such as thin bands of about 0.2 mm in thickness, in a spaced relationship to each other, and a connector bar intersecting the plurality of bands and configured for maintaining the spaced relationship of the bands to each other.
  • the collar may include a plurality of bands, such as from about 2 to about 10 bands, that are positioned parallel to each other.
  • the bands can each be made of a biomedical material, such as polyacetal or a metal, such as titanium or steel.
  • the connector bar of the present invention can be positioned tangential to the plurality of bands, and may have a plurality of grooves configured to receive the thickness of each of the plurality of bands.
  • the grooves also may be beveled to allow for the bands to flex as the heart beats.
  • the connector bar's inner surface can have an outwardly convex curved configuration, and may even include a cushioned portion that can be made from a polymeric material.
  • a pad may be positioned between the collar and the epicardial surface of the heart that may comprise a low durometer polymer, or either a gel-filled cushion or a fluid-filled cushion.
  • the assembly of the present invention may also comprise a closure device for enclosing at least one of the bands in the connector bar.
  • the present invention can reduce the wall tension on one of the chambers of the heart.
  • a yoke or collar is surrounds the heart so as to provide the chamber of the heart as at least two contiguous communicating regions, such as sections of truncated ellipsoids, which have a lesser minimum radii than the chamber before restructuring.
  • the collar displaces at least two portions of the chamber wall inwardly from the unrestricted position.
  • FIG. 1 partial frontal anterior view of an exemplar natural heart
  • FIG. 2 vertical cross sectional view of an exemplar natural heart and blood vessels leading to and from the natural heart;
  • FIG. 3 is a horizontal cross sectional view of an unrestrained left ventricle of the natural heart
  • FIG. 4 is a horizontal cross sectional view of a heart restrained made in accordance with the present invention.
  • FIG. 5 is a perspective view of a device made in accordance with the present invention.
  • FIG. 6 is an enlarged exploded perspective view of a portion of the assembly made in accordance with the present invention.
  • FIG. 7 is an enlarged perspective view of another portion of the assembly made in accordance with the present invention.
  • FIG. 8 is a cross sectional view of a connector of the present invention taken along line 8 - 8 in FIG. 7;
  • FIG. 9A is a partial horizontal cross sectional view of an assembly made in accordance with the present invention while the heart is at rest;
  • FIG. 9B is a partial horizontal cross sectional view of an assembly made in accordance with the present invention while the heart is contracting:
  • FIG. 10 is a perspective view of the assembly made in accordance with the present invention and positioned in the left ventricle;
  • FIG. 11 is an alternative embodiment of the assembly made in accordance with the present invention.
  • FIG. 12 is a cross sectional view of one embodiment of the collar of the present invention taken along line 12 - 12 in FIG. 11;
  • FIG. 13 is another alternative embodiment of the assembly made in accordance with the present invention.
  • FIG. 14 is yet another alternative embodiment of the assembly made in accordance with the invention.
  • FIG. 15 is another alternative embodiment of the assembly made in accordance with the present invention.
  • FIG. 16 is a vertical cross sectional view of one embodiment of an auxiliary fastener made in accordance with the present invention.
  • FIG. 17 is another vertical cross sectional view of the auxiliary fastener of FIG. 16 inserted into the assembly;
  • FIG. 18 the vertical cross sectional view of the embodiment of FIG. 16 illustrating the auxiliary connecter
  • FIG. 19 is a vertical cross sectional view of the auxiliary fastener of FIG. 16 a period of time after being inserted into position.
  • an exemplary natural heart generally indicated in FIGS. 1 and 2 as 10 , has a lower portion comprising two chambers, namely a left ventricle 12 and a right ventricle 14 , which function primarily to supply the main force that propels blood through the circulatory system, namely the pulmonary circulatory system, which propels blood to and from the lungs, and the peripheral circulatory system, which propels blood through the remainder of the body.
  • a natural heart 10 also includes an upper portion having two chambers, a left atrium 16 and a right atrium 18 , which primarily serve as an entryway to the left and right ventricles 12 and 14 , respectively, and assist in moving blood into the left and right ventricles 12 or 14 .
  • the interventricular wall 40 of cardiac tissue 32 separates the left and right ventricles 12 and 14
  • the atrioventricular wall 42 of cardiac tissue 32 separates the lower ventricular region from the upper atrium region.
  • the left and right ventricles 12 and 14 each has a cavity 13 and 15 , respectively, that is in fluid communication with cavities 17 and 19 , respectively, of the atria (e.g., 16 and 18 ) through an atrioventricular valve 50 (which are each illustrated as being in the closed position in FIG. 2). More specifically, the left ventricle cavity 13 is in fluid communication with the left atrium cavity 17 through the mitral valve 52 , while the right ventricle cavity 15 is in fluid communication with the right atrium cavity 19 through the tricuspid valve 54 .
  • the cavities of the ventricles are each in fluid communication with the circulatory system (i.e., the pulmonary and peripheral circulatory systems) through a semilunar valve 44 (which are each illustrated as being in the open position in FIG. 2). More specifically, the left ventricle cavity 13 is in fluid communication with the aorta 26 of the peripheral circulatory system through the aortic valve 46 , while the right ventricle cavity 15 is in fluid communication with the pulmonary artery 28 of the pulmonary circulatory system through the pulmonic valve 48 .
  • Blood is returned to the heart 10 through the atria (e.g., 16 and 18 ). More specifically, the superior vena cava 22 and inferior vena cava 24 are in fluid communication with and deliver blood, as it returns from the peripheral circulatory system, to the right atrium 18 and its cavity 19 .
  • the pulmonary veins 30 are in fluid communication with and delivers blood, as it returns from the pulmonary circulatory system, to the left atrium 16 , and its cavity 17 .
  • the heart 10 is enclosed in the thoracic cavity within a double walled sac commonly referred to as the pericardium. Its inner layer is the visceral pericardium or epicardium, and its outer layer is the parietal pericardium.
  • the heart 10 is generally made up of, among other materials, cardiac muscle or tissue 32 , which has an exterior surface commonly known as the epicardial surface 34 and an interior surface, or endocardial surface 38 , that generally defines the cavities (e.g., ventricular cavities 13 and 15 , respectively, and atrial cavities 17 and 19 , respectively).
  • Coronary arteries 36 on the epicardial surface 34 of the heart 10 provide blood and nourishment (e.g., oxygen) to the heart 10 and its cardiac tissue 32 .
  • the present invention will be discussed in terms of embodiments that are used to primarily assist in the restructuring or reconfiguring, and/or operation of the left ventricle chamber (e.g., 12 ) of the natural heart 10 .
  • the present invention can also be used to assist in the restructuring or reconfiguring, and/or operation of other portions of the natural heart 10 , such as either atria ( 16 and/or 18 ), or the right ventricle chamber (e.g., 14 ).
  • the chambers of the heart 10 is generally shaped as a hollow truncated ellipsoid having, at any circular cross-section perpendicular to its long axis, a center point “C 1 ” and a radius “R 1 ” extending from center point C 1 to the endocardial surface 38 .
  • the cardiac tissue 32 of the heart 10 has a thickness “w,” which is generally the distance between the epicardial surface 34 and the endocardial surface 38 .
  • the assembly 60 of the present invention exemplified in FIGS. 4 to 7 preferably is configured and positioned relative to the natural heart 10 to displace at least two portions of the cardiac tissue 32 inwardly (see, e.g., FIG. 4) from the unrestricted position, as exemplified in FIG. 3.
  • the shape of the chamber (e.g., the left ventricle chamber 12 ) of the heart 10 is generally restructured or reconfigured from a generally hollow truncated ellipsoid (see, e.g., FIG.
  • each of the truncated ellipsoids has an adjusted radius “R 2 ,” which is preferably shorter than radius “R 1 .”
  • the assembly 60 can be static in that it does not actuate or pump the heart 10 , but rather, displaces and holds portions of the cardiac tissue 32 in a generally predetermined fixed position as the heart 10 continues to contract (e.g., beat) and pump blood through its chambers and through the body's circulatory system. Nevertheless, the assembly 60 can be configured and constructed to permit torsional deformation as the natural heart 10 beats.
  • the assembly 60 can include a yoke or collar 62 , as exemplified in FIGS. 5 - 7 , to assist in restraining or restructuring a ventricle, such as the left ventricle chamber 12 .
  • Collar 62 can be any desired shape and preferably surrounds or encircles the heart 10 , and preferably one chamber (e.g., the left ventricle chamber 12 ) as best exemplified in FIG. 10, so as to restructure or reconfigure the left ventricle chamber 12 as having a shape approximating at least two continuous communicating portions of truncated ellipsoids.
  • a portion or region 64 of the collar 62 can extend along the longitudinal plane or along the longer axis of the chamber. Suitable locations on the epicardial surface 34 for the region 64 can include the basal portion near the atrioventricular groove 43 (see, e.g., FIG. 1) and apical portion 20 of the heart 10 , the anterolateral surface of the left ventricle chamber 12 , or the posteromedial surface of the left ventricle chamber 12 .
  • the collar 62 may include two or more bands (e.g., 76 ) configured for positioning around the heart 10 .
  • bands 76 are circumferentially flat and may be oriented with the surface 78 being positioned generally tangent to the epicardial surface 34 of the heart 10 , and having the smaller dimension, as compared with surface 80 .
  • Surface 80 is generally oriented perpendicular to the epicardial surface 34 .
  • Band 76 should be sized so as to provide for low deformation in the direction perpendicular to the epicardial surface 34 of the heart 10 , but only require a low strain energy for tortial deformation as the heart 1 O beats.
  • Band 76 can have a thickness “th” across surface 78 and a width “w” across surface 80 , that each varies depending on the selected material and its particular deformation characteristics.
  • the band 76 can have a thickness “h” across surface 78 of about 0.2 mm, and can have a width, “w” across surface 80 from about 5 mm to about 12 mm, and more preferably, about 7 mm.
  • the particular dimensions of each assembly 60 , and of its components will depend, as will be discussed later, according to particular anatomy, the desired application, and upon the particular size and configuration of the individual natural heart 10 .
  • bands 76 In constructing assembly 60 using bands 76 , from about 2 to about 10 bands 76 may be used, and preferably about 4 bands 76 are used in the present invention. Nevertheless, the number of bands 76 may be selected dependent upon the property of the material selected for each of the bands 76 , as well as the load stress required to appropriately restructure the heart chamber geometry.
  • Bands 76 are each preferably made of a light weight, generally rigid material that has a low bending strain under expected levels of stress so that the material has sufficient wear resistance in use while the heart 10 beats, and maintains its desired shape in use adjacent the heart 10 .
  • suitable materials which may be employed as bands 76 include any biocompatible or biomedical materials, such as metals, including titanium or stainless steel, or a suitable polymer, including polyacetal or an ultra high molecular weight polyethylene, or a combination of the same.
  • the collar 62 may preferably include a connector 82 , and preferably a plurality of connectors 82 spaced along the collar 62 , as exemplified best in FIG. 5.
  • the connectors 82 can assist in maintaining the space relationship of the bands 76 relative to each other, and of the assembly 60 to the heart 10 .
  • the connector 82 preferably has a contact or an inner surface 84 , which is configured for placement adjacent or against the epicardial surface 34 of the natural heart 10 .
  • the inner surface 84 may be configured so that the epicardial surface 34 may slide along inner surface 84 during contraction and expansion of the heart 10 , and to minimize damage to the epicardial surface 34 , and the coronary arteries (e.g., 36 ).
  • the inner surface 84 is curved convex outwardly in a longitudinal plane (see, e.g., FIGS. 4 and 8) and has a smooth surface, and/or preferably rounded edges 87 so that collar 62 can be configured to be positioned adjacent or on the epicardial surface 34 whereby intimate contact can be established and maintained, even during the contraction or beating of the heart 10 .
  • FIGS. 6 - 8 illustrate the connectors 82 as each including one or more grooves 92 , which can extend inwardly from an opening 98 in the outer wall 86 , and toward the contact or inner surface 84 .
  • Each groove 92 is preferably sized and configured to receive a band 76 whereby its surface 78 would be positioned adjacent the base wall 94 , and its surfaces 80 preferably would be positioned adjacent sidewalls 96 .
  • groove 92 should be configured to assist in allowing flexion movement of the band 76 as the heart 10 beats and moves.
  • grooves 92 may be tapered inwardly as the grooves 92 proceeds or extends from the outer surface 86 inwardly toward the contact surface 84 .
  • grooves 92 may also be tapered inwardly as the groove extends from each of the lateral surfaces 88 inwardly (e.g., upwardly and/or downwardly), as best illustrated in FIG. 6.
  • Connectors 82 are each preferably made of a light weight, generally rigid material that has a low bending strain under expected levels of stress so that the material has sufficient wear resistance in use while the heart 10 beats, and maintains its desired shape in use adjacent the heart 10 .
  • suitable materials which may be employed as connectors 82 may include any biocompatible or biomedical materials, such as metals, including titanium or stainless steel, or a suitable polymer, including polyacetal or an ultra high molecular weight polyethylene, or a combination of the same.
  • a structure 100 can be provided so as to assist in maintaining the bands 76 in the groove 92 , in use. Any structure 100 contemplated for use with assembly 60 should assist in restricting movement of the band 76 out of the groove 92 through opening 98 .
  • the structure 100 may take the form of a plate 100 that can be secured or otherwise attached, and preferably releasably secured, to close off or restrict access through one or more openings 98 .
  • sutures (not shown) may also be threaded through the connector 82 to assist in restricting bands 76 movement through opening 98 .
  • Structure 100 is preferably made of a biocompatible or biomedical material.
  • an alternative embodiment of the present invention may include a collar or yoke 162 that provides an essentially continuous surface which contacts the epicardium surface 34 of the heart 10 .
  • collar 162 may take the form of a generally continuous yoke-like structure that is essentially rigid.
  • Collar 162 preferably includes a contact or an inner surface 184 , which is configured for placement adjacent or against the epicardial surface 34 of the natural heart 10 .
  • the inner surface 184 should be configured so that the epicardial surface 34 may slide along the inner surface 184 during contraction and expansion of the natural heart 10 , and to minimize damage to the epicardial surface 34 and the coronary arteries (e.g., 36 ).
  • the inner surface 184 is curved convexly outwardly in a longitudinal plane and has a smooth surface, and/or preferably rounded edges 187 so that a collar 162 can be configured to be positioned adjacent or on the epicardial surface 34 whereby intimate contact can be established arid maintained, even during the contraction or expansion of the natural heart 10 .
  • the collar 162 preferably is selected from a generally rigid biomedical or biocompatable material.
  • suitable materials may include a metal, such as titanium or steel, or a polymer, such as an ultra high molecular weight polyethylene, polyacetal, or a polymer composite material such as carbon fiber-epoxy or fiberglass-epoxy, or a combination of the same.
  • the collar 162 may be covered, either partially or entirely, with a material that promotes tissue ingrowth into the collar 162 , such as a soft tissue polyester fabric sheeting or polyletrafluroethyhere (PTFE).
  • PTFE polyletrafluroethyhere
  • the collar 162 may include an attachment system 163 that allows the collar 162 to be placed around the heart 10 , such as inbetween the pulmonary veins 30 near the basal portion of the heart 10 so as to reduce the possibility of lateral or medical displacement of the assembly 60 , or about the lateral atrium or the atrioventrialar groove region.
  • the collar 162 may include an attachment system 163 that permits the collar 162 to be separated and then reattached at two or more sites or positions along the collar 162 , preferably adjacent or near the region of the collar 162 configured for placement adjacent or on the basal portion and/or apical portion 20 of the natural heart 10 .
  • the attachment system 163 is illustrated as an interlocking pin 163 B and receptacle 163 A (e.g., a ball and socket-likejoint), it is contemplated, and as would be appreciated by those skilled in the art, other devices and assemblies for releaseably securing the collar 162 together can be used.
  • Example of such devices and assemblies for attachment system 163 could include sutures, a screw and bore holes through overlapping portions of the collar 162 , clamps, a combination of these devices and assemblies.
  • the collar 162 may include an attachment system 163 at one site along the collar 162 , preferably adjacent or at the portion of the collar 162 configured for placement adjacent on or the basal portion of the heart 10 .
  • This embodiment of collar 162 preferably would include a portion 167 that can either include flexible material or a pivotable section 168 to provide movement of the collar 162 so that the attachment assembly 163 can open, and the collar 162 can be slipped around in the heart 10 , and/or between the pulmonary veins 30 .
  • the assembly 260 may include a collar 262 having a region 264 similar to the structure of the collar 62 , exemplified above in FIGS. 4 - 8 , and connector portions or regions 268 , similar to the structure of the collar 162 , discussed above, and exemplified in FIGS. 12 - 14 .
  • a pad 56 can be positioned and/or interposed between the epicardial surface 34 and the inner surface 84 of one or more of the connectors 82 .
  • Pad 56 can be, as exemplified in FIGS. 9A and 9B, a fluid-filled or gel-filled pad or cushion, which generally will occupy space laterally beyond the collar 62 and the lateral portions 85 of inner surface 84 while the heart 10 is in as a relaxed state. However, as the heart 10 contracts and the wall shortens (see, e.g., FIG.
  • the epicardial surface 34 will “peel away” from the collar 62 and the lateral portions 85 of inner surface 84 and thus, fluid or gel in the pads 56 can fill this space so that the inner surface 84 and epicardial surface 34 remain in contact and effect focal restraint whereby the chamber 12 is restructured, as detailed above.
  • the pad 56 is a closed system.
  • pad 56 can be configured such that fluid and/or gel can be added or removed to enhance functionality of the device assembly of the present invention, as desired.
  • one or more lines 58 can be in fluid communication with a chamber in pad 56 .
  • Line 58 can extend from pad 56 to an injection port 59 , which can be positioned subcutaneous or elsewhere, as desired, for enhanced access.
  • fluid or gel can be injected into the injection port 59 using a standard syringe and needle, or other device, to increase the size of the pad 56 and/or the pressure within the pad 56 , as desired.
  • fluid or gel can be withdrawn as desired.
  • pad 56 can be as a low durometer polymer such as a plastic or other material (e.g., rubber).
  • the-material accommodates and maintains the contact between the collar 62 , and more specifically its inner surface 84 , and epicardial surface 34 and thus, the desired reconfiguration of the heart 10 as the heart 10 beats or deforms.
  • auxiliary connector 70 can take the form of various mechanical connectors used in the industry to attach and position prosthetic devices in the body.
  • Auxiliary connector 70 can take the form of a spike shaped object or pin 75 that is configured to penetrate the epicardial surface 34 into the cardiac tissue 32 .
  • auxiliary connector 74 can take the form of a button 72 and cord 73 .
  • One end of the cord 73 can be attached or otherwise secured to the collar 62 , and it can extend inwardly into and through the cardiac tissue 32 .
  • a button 72 can be attached to or adjacent the other end of the cord 86 adjacent the endocardial surface 38 .
  • Button 72 can be made of any biocompatible material, and is preferably made of a material that enhances tissue growth around the button 72 to minimize the possibility of the formation of blood clots. It is further contemplated that other surgical attachment articles and techniques can be used in accordance with the present invention, such as screws, surgical staples and the like, to assist in fastening and securing the assembly 60 in position, as desired.
  • auxiliary connector 70 can take the form of a peg 74 , as exemplified in FIGS. 16 - 19 , that can configured to be lockably received in a hole 67 positioned and/or aligned on the assembly 60 , and preferably on the connectors 82 or the collar 162 .
  • Peg 74 generally comprises a generally permanent potion 74 A configured preferably to be snugly received in the hole 67 , as discussed above.
  • the portion 74 A can be made of any suitable biomedical or biocompatible material. Suitable examples of materials for portion 74 A, can include the same materials that can be used with the collar 62 , as exemplified above.
  • a generally rigid absorbable spike 74 B is provided, which preferably is a generally fustoconicall shaped and tapers inwardly as the spike 74 B extends away from the portion 74 A.
  • Spike 74 B is sufficiently rigid so that it can pierce the tissue and then be inserted into the muscle tissue (e.g., the cardiac tissue 32 ).
  • the material used for spike 74 B should be a material that is absorbable by the body tissue over a period of time.
  • Suitable materials can include a gelatin material, which can be partially denatured thermally or chemically to control solubility and the absorption rate in the tissue (e.g., 32 ), a polyglycol acid, or other materials, as will be appreciated by those skilled in the industry, used with absorbable surgical devices or sutures.
  • extension 74 C configured, for example, as a strip, coil, tube, or loop which preferably may include exposed interstices (mesh), holes, loops or other surface enhancements to promote tissue in growth.
  • Extension 74 C can be made from a material to enhance tissue integration therein. Suitable examples of materials for use as extension 74 C can include polyester, polypropylene, and other polymers used in as non-dissoluble implants.
  • the assembly 60 should be so configured and positioned adjacent the heart 10 whereby the wall tension is reduced in accordance with LaPlace's theory of a chamber, which is as follows:
  • K is a proportionality constant
  • the inner radius “R 1 ” (of the slice or plane) of the unrestricted heart 10 is about 28.982 mm and that the heart 10 has an outer radius of about 38.406 mm.
  • the width “w” and radius “R 1 ” can be directly obtained from high-resolution imaging, such as an echocardiogram, or preferably, by computation based on an assumed geometric model.
  • the ratio of the restraint contract pressure of the left ventricle 12 of the device 60 to the cavity pressure can vary from 1 to about 2.
  • the distance inwardly that the heart 10 should be displaced can be calculated so that the desired restructuring can be achieved. If “e” is the distance that the center of either member 62 is to be separated from the absolute center of a remodeled ventricle in this plane, then:
  • twice e or (2*e) is 64.42 mm, and this is the preferred distance separating the oppositely disposed inner surfaces 64 .
  • the wall of the heart 10 needs to be displaced or moved inwardly about 6.20 mm from the unrestrained position to achieve the desired restructure or reconfiguration whereby wall tension is adjusted, as desired. Also, using the formula 2 ⁇ g to calculate the desired contacting width of the inner surface 84 , which is about 11.68 mm in this example.
  • a high resolution image such as a standard echocardiogram, or other analysis of the heart 10 is preferred so that certain anatomical measurements can be electronically, preferably digitally, recorded and calculated, as detailed above. While the present application only includes one set of mathematic calculations to optimize the present invention, it is contemplated that measurements will need to be taken along several axes, planes, locations or positions along the longer axis of the chamber. Pre-surgical calculations are preferred so that the assembly 60 can be constructed, as desired, before surgery to minimize surgical time, and preferably reduce or eliminate use of a heart/lung bypass machine.
  • Thoracic surgery may be required to implant assembly 60 .
  • Clinically sufficient anesthesia is administered and standard cardiac monitoring is employed to the patient and then, via a sternal or lateral wall incision, the pericardial sac where the heart 10 is usually situated is opened using standard thoracic surgical procedures, which are known to those skilled in the art.
  • inflow to the heart 10 may be occluded. This can be accomplished by placing a tourniquet around either the superior and/or inferior vena cava 22 and 24 , respectively, as illustrated respectfully in FIGS. 1 and 2, for a brief period of time (e.g., about 3 to 4 heartbeats) whereby the heart 10 shrinks and empties. Thereafter, the collar 62 may be slipped around the heart 10 . The tourniquets can be released from occlusion around the superior and/or inferior vena cavas 22 and 24 , respectively, and the heart 10 re-fills with blood.
  • hypothennia techniques may be employed to lower body temperature to reduce the side effects that can be caused by reduced blood pressure in the circulatory system.
  • the present invention can be inserted on and/or into the patient. If so, referring back now to FIG. 2, the superior vena cava 22 , the inferior vena cava 24 , and aorta 26 are cannulated.
  • the circulatory system is connected to as a cardiopulmonary bypass machine so that circulation and oxidation of the blood are maintained during the surgical procedure.
  • the procedure discussed in detail will be for insertion of the present invention 60 to restructure or reconfigure the left ventricle chamber 12 .
  • assembly 60 which may have been customized according to the anatomical measurements and calculations, is preferably positioned adjacent or against the epicardial surface 34 in predetermined locations relative to each other and relative to the chamber (e.g., left ventricle chamber 12 ). Assembly 60 is positioned around the heart 10 so that portions of the heart 10 are displaced or urged inwardly, as desired.
  • Auxiliary connectors 70 can be used to further secure the assembly 60 to the heart 10 .
  • peg 74 can be inserted in the hole 67 , whereby the spike 74 B is piercing the epicardial surface 34 and is being inserted into the tissue (e.g., cardiac tissue 32 ).
  • Peg 74 preferably locks into position once inserted (see FIG. 17), to further secure the assembly 60 in place. Over time, it is preferred that spike 74 B, which has been inserted into the tissue, dissolve and be absorbed by the surrounding tissue.
  • extension 74 C becomes exposed to the tissue, and tissue thereby insinuates and grows into any exposed interstices, loops, holes, or other surface enhancements to promote tissue ingrowth.
  • the peg 74 B can thereafter be held in place by the tissue insinuation and growth into extension 74 C, which can assist in maintaining the position of assembly 60 .
  • the collar 162 exemplified in FIGS. 13 and 14, can be placed around the heart 10 , either between the pulmonary artery 28 and the superior left atrial surface or between the aorta and the pulmonary artery 28 and then across the posterior dorsal left atrial surface in between the left and right pulmonary veins 30 .
  • a portion of the collar 162 preferably the posterior portion, can be placed behind the heart 10 .
  • An opening is sharply and/or bluntly developed in the leaves of the pericardium forming the anterolateral margin of the oblique sinus. Then, a hemostat can be used to place a portion of the collar 162 through the opening.
  • a detachable cord with one end attached to the portion of the collar 162 , can be grasped and used to pull a portion of the collar 162 through the opening.
  • a detachable cord with one end attached to the portion of the collar 162 , can be grasped and used to pull a portion of the collar 162 through the opening.
  • An alternative method for positioning the present invention includes removing the natural heart 10 from the patient, positioning all the components of the present invention assembly 60 , as discussed above, and auto-transplanting the natural heart 10 back into the patient using standard cardiectomy and cardiac transplant techniques known in the industry.

Abstract

A geometric reconfiguration assembly for the natural heart having a collar configured for surrounding the natural heart. The collar can include a plurality of bands, such as thin bands of about 0.2 mm in thickness, in a spaced relationship to each other, and a connector bar intersecting the plurality of bands and configured for maintaining the spaced relationship of the bands to each other. The collar may include a plurality of bands, such as from about 2 to about 10 bands, that are positioned parallel to each other. The bands can each be made of a biomedical material, such as polyacetal or a metal, such as titanium or steel.
The connector bar of the present invention can be positioned tangential to the plurality of bands, and may have a plurality of grooves configured to receive the thickness of each of the plurality of bands. The grooves also may be beveled to allow for the bands to flex as the heart beats. The connector bar's inner surface can have an outwardly convex curved configuration, and may even include a cushioned portion that can be made from a polymeric material. A pad may be positioned between the collar and the epicardial surface of the heart that may comprise a low durometer polymer, or either a gel-filled cushion or a fluid-filled cushion.

Description

    REFERENCE TO COPENDING APPLICATION
  • This is a continuation in part application of U.S. patent application Ser. no. 08/581,914, filed Dec. 23, 1997, entitled “Activation Device for the Natural Heart and Method of Doing the Same,” which is a continued prosection application of U.S. patent application Ser. No. 08/581,914 filed on Jan. 2, 1996.[0001]
  • TECHNICAL FIELD OF THE INVENTION
  • The present invention relates to a device and method for treating cardiomyopathies and/or enlarged hearts and more specifically, a device and method for decreasing a heart chamber's wall tension. [0002]
  • BACKGROUND OF THE INVENTION
  • The natural heart, and specifically, the cardiac muscle tissue of the natural heart (e.g., myocardium) can fail for various reasons to a point where the natural heart cannot provide sufficient circulation of blood for a body so that life can be maintained. More specifically, the heart and its chambers can become enlarged for a variety of causes and/or reasons, including viral disease, idiopathic disease, valvular disease (mitral, aortic and/or both), ischemic disease, [0003]
  • Chagas' disease and so forth. As the heart and its chambers enlarge, tension of the walls of the heart's chambers increase and thus, the heart must develop more wall tensile stress to generate the needed pressure for pumping blood through the circulatory system. The process of ventricular dilation is generally the result of chronic volume overload or specific damage to the myocardium. In a normal heart that is exposed to long-term increased cardiac output requirements, for example, that for an athlete, there is an adaptive process of slight ventricular dilation and muscle myocyte hypertrophy. In this way, the heart may fully compensate for the increase cardiac output requirements of the body. With damage to myocardium or chronic volume overload, however, there are increased requirements put on the contracting myocardium to such a level that this compensated state is never achieved and the heart continues to dilate. [0004]
  • A problem with an untreated dilated ventricle is that there is a significant increase in wall tension and/or stress, both during the diastolic filling, and during the systolic contraction. In a normal heart, the adaption of muscle hypertrophy (e.g. thickening) in the ventricular dilation maintain a fairly constant wall tension for systolic constriction. However, in a failing heart, the ongoing dilation is greater than the hypertrophy, and as a result, rising wall tension is required for systolic contraction. This is believed to result in further muscle damage. [0005]
  • The increase in wall stress is also true for diastolic filling. Additionally, because of the lack of cardiac output, ventricular filling pressure tends to rise due to several physiologic mechanisms. Moreover, in diastole, both the diameter and wall pressure increase over normal levels, thus contributing to higher wall stress levels. As a solution for the enlarged natural heart, attempts have been made in the past to provide a treatment to maintain circulation. Prior treatment for heart failure generally fall into three categories, namely surgical treatments; mechanical support systems; or pharmacological. [0006]
  • One such approach has been to replace the existing natural heart in a patient with an artificial heart or a ventricular assist device. In using artificial hearts and/or assist devices, a particular problem stems from the fact that the materials used for the interior lining of the chambers of an artificial heart are in direct contact with the circulating blood, which can enhance undesirable clotting of the blood, build up of calcium, or otherwise inhibit the blood's normal function. Hence, thromboembolism and hemolysis could occur with greater ease. Additionally, the lining of an artificial heart or a ventricular assist device can crack, which inhibits performance, even if the crack is at a microscopic level. Moreover, these devices must be powered by a source which can be cumbersome and/or external to the body. Drawbacks have limited use of these devices to applications having too brief a time period to provide a real lasting benefit. [0007]
  • An alternative procedure is to transplant a heart from another human or animal into a patient. The transplant procedure requires removing an existing organ (i.e., the natural heart) for substitution with another organ (i.e., another natural heart) from another human, or potentially, from an animal. Before replacing an existing organ with another, the substitute organ must be “matched” to the recipient, which can be, at best, difficult and time consuming to accomplish. Furthermore, even if the transplanted organ matches the recipient, a risk exists that the recipient's body will reject the transplanted organ and attack it as a foreign object. Moreover, the number of potential donor hearts is far less than the number of patients in need of a transplant. Although use of animal hearts would lessen the problem with fewer donors than recipients, there is an enhanced concern with rejection of the animal heart. [0008]
  • In an effort to use the existing natural heart of a patient, other attempts have been made to reduce wall tension of the heart by removing a portion of the heart wall, such as a portion of the left ventricle in a partial left ventriculectomy procedure (the Batista procedure). A wedge-shaped portion of the ventricular muscle has been removed, which extends from the apex to the base of the heart. By reducing the chamber's volume, and thus its radius, the tension of the chamber's wall is reduced as well. There are, however, several drawbacks with such a procedure. First, a valve (i.e., the mitral valve) may need to be repaired or replaced depending on the amount of cardiac muscle tissue to be removed. Second, the procedure is invasive and traumatic to the patient. As such, blood loss and bleeding can be substantial during and after the procedure. Moreover, as can be appreciated by those skilled in the industry, the procedure is not reversible. [0009]
  • Another device developed for use with an existing heart for sustaining the circulatory function of a living being and the pumping action of the natural heart is an external bypass system, such as a cardiopulmonary (heart-lung) machine. Typically, bypass systems of this type are complex and large, and, as such, are limited to short term use in an operating room during surgery, or to maintaining the circulation of a patient while awaiting receipt of a transplant heart. The size and complexity effectively prohibit use of bypass systems as a long term solution, as they are rarely even portable devices. Furthermore, long term use of these systems can damage the blood cells and blood borne products, resulting in post surgical complications such as bleeding, thromboembolism function, and increased risk of infection. [0010]
  • Medicines have been used to assist in treating cardiomyopathies. Some inotropic agents can stimulate cardiac work. For example, digoxin can increase the contractibility of the heart, and thereby enhances emptying of the chambers during systolic pumping. Medicines, such as diuretics or vasodilators attempt to reduce or decrease the heart's workload. For example, indirect vasodilators, such as angiotensin-converting enzyme inhibitors (e.g., enalopril), can help reduce the tendency of the heart to dilate under the increased diastolic pressure experienced when the contractibility of the heart muscle decreases. Many of these medicines have side effects, such as excessive lowering of blood pressure, which make them undesirable for long term therapy. [0011]
  • As can be seen, currently available treatments, procedures, medicines, and devices for treating end-stage cardiomyopathies have a number of shortcomings that contribute to the complexity of the procedure or device. The current procedures and therapies can be extremely invasive, only provide a benefit for a brief period of time, or have undesirable side effects which can hamper the heart's effectiveness. There exists a need in the industry for a device and procedure that can use the existing heart to provide a practical, long-term therapy to reduce wall tension of the heart, and thus improve its pumping efficiency. [0012]
  • SUMMARY OF THE PRESENT INVENTION
  • It is the object of the present invention to provide a device and method for treating cardiomyopathies that addresses and overcomes the above-mentioned problems and shortcomings in the thoracic medicine art. [0013]
  • It is another object of the present invention to provide a device and method for treating cardiomyopathies that minimizes damage to the coronary circulatory and the endocardium. [0014]
  • It is still a further another object of the present invention to provide a device and method for treating cardiomyopathies that maintains the stroke volume of the heart. [0015]
  • Another object of the present invention is to provide a device and method for treating cardiomyopathies that supports and maintains the competence of the heart valves so that the heart valves can function as intended. [0016]
  • Still another object of the present invention is to provide a device and method that increases the pumping effectiveness of the heart. [0017]
  • Yet another object of the present invention is to provide a device and method for treating cardiomyopathies on a long term basis. [0018]
  • It is yet still an object of the present invention to provide a device and method for treating cardiomyopathies that does not require removal of any portion of an existing natural heart. [0019]
  • Still a further object of the present invention is to provide a device and method for treating dilated cardiomyopathies that directly reduce the effective radius of a chamber of a heart in systole as well as in diastole. [0020]
  • Additional objects, advantages, and other features of the present invention will be set forth and will become apparent to those skilled in the art upon examination of the following, or may be learned with practice of the invention. [0021]
  • To achieve the foregoing, a geometric reconfiguration assembly for the natural heart having a collar configured for surrounding the natural heart. The collar can include a plurality of bands, such as thin bands of about 0.2 mm in thickness, in a spaced relationship to each other, and a connector bar intersecting the plurality of bands and configured for maintaining the spaced relationship of the bands to each other. The collar may include a plurality of bands, such as from about 2 to about 10 bands, that are positioned parallel to each other. The bands can each be made of a biomedical material, such as polyacetal or a metal, such as titanium or steel. [0022]
  • The connector bar of the present invention can be positioned tangential to the plurality of bands, and may have a plurality of grooves configured to receive the thickness of each of the plurality of bands. The grooves also may be beveled to allow for the bands to flex as the heart beats. The connector bar's inner surface can have an outwardly convex curved configuration, and may even include a cushioned portion that can be made from a polymeric material. A pad may be positioned between the collar and the epicardial surface of the heart that may comprise a low durometer polymer, or either a gel-filled cushion or a fluid-filled cushion. [0023]
  • The assembly of the present invention may also comprise a closure device for enclosing at least one of the bands in the connector bar. [0024]
  • In use, the present invention can reduce the wall tension on one of the chambers of the heart. A yoke or collar is surrounds the heart so as to provide the chamber of the heart as at least two contiguous communicating regions, such as sections of truncated ellipsoids, which have a lesser minimum radii than the chamber before restructuring. As such, the collar displaces at least two portions of the chamber wall inwardly from the unrestricted position.[0025]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • While the specification concludes with claims particularly pointing out and distinctly claiming the present invention, it is believed the same will be better understood from the following description taken in conjunction with the accompanied drawings in which: [0026]
  • FIG. 1 partial frontal anterior view of an exemplar natural heart; [0027]
  • FIG. 2 vertical cross sectional view of an exemplar natural heart and blood vessels leading to and from the natural heart; [0028]
  • FIG. 3 is a horizontal cross sectional view of an unrestrained left ventricle of the natural heart; [0029]
  • FIG. 4 is a horizontal cross sectional view of a heart restrained made in accordance with the present invention; [0030]
  • FIG. 5 is a perspective view of a device made in accordance with the present invention; [0031]
  • FIG. 6 is an enlarged exploded perspective view of a portion of the assembly made in accordance with the present invention; [0032]
  • FIG. 7 is an enlarged perspective view of another portion of the assembly made in accordance with the present invention; [0033]
  • FIG. 8 is a cross sectional view of a connector of the present invention taken along line [0034] 8-8 in FIG. 7;
  • FIG. 9A is a partial horizontal cross sectional view of an assembly made in accordance with the present invention while the heart is at rest; [0035]
  • FIG. 9B is a partial horizontal cross sectional view of an assembly made in accordance with the present invention while the heart is contracting: [0036]
  • FIG. 10 is a perspective view of the assembly made in accordance with the present invention and positioned in the left ventricle; [0037]
  • FIG. 11 is an alternative embodiment of the assembly made in accordance with the present invention; [0038]
  • FIG. 12 is a cross sectional view of one embodiment of the collar of the present invention taken along line [0039] 12-12 in FIG. 11;
  • FIG. 13 is another alternative embodiment of the assembly made in accordance with the present invention; [0040]
  • FIG. 14 is yet another alternative embodiment of the assembly made in accordance with the invention; [0041]
  • FIG. 15 is another alternative embodiment of the assembly made in accordance with the present invention; [0042]
  • FIG. 16 is a vertical cross sectional view of one embodiment of an auxiliary fastener made in accordance with the present invention; [0043]
  • FIG. 17 is another vertical cross sectional view of the auxiliary fastener of FIG. 16 inserted into the assembly; [0044]
  • FIG. 18 the vertical cross sectional view of the embodiment of FIG. 16 illustrating the auxiliary connecter; and [0045]
  • FIG. 19 is a vertical cross sectional view of the auxiliary fastener of FIG. 16 a period of time after being inserted into position.[0046]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • Referring now to the figures in detail wherein like numerals indicate the same elements throughout the views, an exemplary natural heart, generally indicated in FIGS. 1 and 2 as [0047] 10, has a lower portion comprising two chambers, namely a left ventricle 12 and a right ventricle 14, which function primarily to supply the main force that propels blood through the circulatory system, namely the pulmonary circulatory system, which propels blood to and from the lungs, and the peripheral circulatory system, which propels blood through the remainder of the body. a natural heart 10 also includes an upper portion having two chambers, a left atrium 16 and a right atrium 18, which primarily serve as an entryway to the left and right ventricles 12 and 14, respectively, and assist in moving blood into the left and right ventricles 12 or 14. The interventricular wall 40 of cardiac tissue 32 separates the left and right ventricles 12 and 14, and the atrioventricular wall 42 of cardiac tissue 32 separates the lower ventricular region from the upper atrium region.
  • Generally, the left and [0048] right ventricles 12 and 14, respectively, each has a cavity 13 and 15, respectively, that is in fluid communication with cavities 17 and 19, respectively, of the atria (e.g., 16 and 18) through an atrioventricular valve 50 (which are each illustrated as being in the closed position in FIG. 2). More specifically, the left ventricle cavity 13 is in fluid communication with the left atrium cavity 17 through the mitral valve 52, while the right ventricle cavity 15 is in fluid communication with the right atrium cavity 19 through the tricuspid valve 54.
  • Generally, the cavities of the ventricles (e.g., [0049] 13 and 15) are each in fluid communication with the circulatory system (i.e., the pulmonary and peripheral circulatory systems) through a semilunar valve 44 (which are each illustrated as being in the open position in FIG. 2). More specifically, the left ventricle cavity 13 is in fluid communication with the aorta 26 of the peripheral circulatory system through the aortic valve 46, while the right ventricle cavity 15 is in fluid communication with the pulmonary artery 28 of the pulmonary circulatory system through the pulmonic valve 48.
  • Blood is returned to the [0050] heart 10 through the atria (e.g., 16 and 18). More specifically, the superior vena cava 22 and inferior vena cava 24 are in fluid communication with and deliver blood, as it returns from the peripheral circulatory system, to the right atrium 18 and its cavity 19. The pulmonary veins 30 are in fluid communication with and delivers blood, as it returns from the pulmonary circulatory system, to the left atrium 16, and its cavity 17.
  • The [0051] heart 10 is enclosed in the thoracic cavity within a double walled sac commonly referred to as the pericardium. Its inner layer is the visceral pericardium or epicardium, and its outer layer is the parietal pericardium. The heart 10 is generally made up of, among other materials, cardiac muscle or tissue 32, which has an exterior surface commonly known as the epicardial surface 34 and an interior surface, or endocardial surface 38, that generally defines the cavities (e.g., ventricular cavities 13 and 15, respectively, and atrial cavities 17 and 19, respectively). Coronary arteries 36 on the epicardial surface 34 of the heart 10 provide blood and nourishment (e.g., oxygen) to the heart 10 and its cardiac tissue 32.
  • By way of a non-limiting example, the present invention will be discussed in terms of embodiments that are used to primarily assist in the restructuring or reconfiguring, and/or operation of the left ventricle chamber (e.g., [0052] 12) of the natural heart 10. However. it is noted that the present invention can also be used to assist in the restructuring or reconfiguring, and/or operation of other portions of the natural heart 10, such as either atria (16 and/or 18), or the right ventricle chamber (e.g., 14).
  • Turning now to FIG. 3, the chambers of the [0053] heart 10, including the left ventricle chamber 12, is generally shaped as a hollow truncated ellipsoid having, at any circular cross-section perpendicular to its long axis, a center point “C1” and a radius “R1” extending from center point C1 to the endocardial surface 38. The cardiac tissue 32 of the heart 10 has a thickness “w,” which is generally the distance between the epicardial surface 34 and the endocardial surface 38.
  • The [0054] assembly 60 of the present invention exemplified in FIGS. 4 to 7 preferably is configured and positioned relative to the natural heart 10 to displace at least two portions of the cardiac tissue 32 inwardly (see, e.g., FIG. 4) from the unrestricted position, as exemplified in FIG. 3. By displacing portions of the cardiac tissue 32 inwardly, the shape of the chamber (e.g., the left ventricle chamber 12) of the heart 10 is generally restructured or reconfigured from a generally hollow truncated ellipsoid (see, e.g., FIG. 3) to a chamber generally shaped as having at least two continuous communicating portions of truncated ellipsoids (see, e.g., FIG. 4). In generally reconfiguring or restructuring the heart 10 as such, each of the truncated ellipsoids has an adjusted radius “R2,” which is preferably shorter than radius “R1.”
  • The [0055] assembly 60 can be static in that it does not actuate or pump the heart 10, but rather, displaces and holds portions of the cardiac tissue 32 in a generally predetermined fixed position as the heart 10 continues to contract (e.g., beat) and pump blood through its chambers and through the body's circulatory system. Nevertheless, the assembly 60 can be configured and constructed to permit torsional deformation as the natural heart 10 beats.
  • The [0056] assembly 60 can include a yoke or collar 62, as exemplified in FIGS. 5-7, to assist in restraining or restructuring a ventricle, such as the left ventricle chamber 12. Collar 62 can be any desired shape and preferably surrounds or encircles the heart 10, and preferably one chamber (e.g., the left ventricle chamber 12) as best exemplified in FIG. 10, so as to restructure or reconfigure the left ventricle chamber 12 as having a shape approximating at least two continuous communicating portions of truncated ellipsoids. Preferably, a portion or region 64 of the collar 62 can extend along the longitudinal plane or along the longer axis of the chamber. Suitable locations on the epicardial surface 34 for the region 64 can include the basal portion near the atrioventricular groove 43 (see, e.g., FIG. 1) and apical portion 20 of the heart 10, the anterolateral surface of the left ventricle chamber 12, or the posteromedial surface of the left ventricle chamber 12.
  • The [0057] collar 62 may include two or more bands (e.g., 76) configured for positioning around the heart 10. Preferably, bands 76 are circumferentially flat and may be oriented with the surface 78 being positioned generally tangent to the epicardial surface 34 of the heart 10, and having the smaller dimension, as compared with surface 80. Surface 80 is generally oriented perpendicular to the epicardial surface 34. Band 76 should be sized so as to provide for low deformation in the direction perpendicular to the epicardial surface 34 of the heart 10, but only require a low strain energy for tortial deformation as the heart 1O beats. Band 76 can have a thickness “th” across surface 78 and a width “w” across surface 80, that each varies depending on the selected material and its particular deformation characteristics. When metallic material is used with the present invention, the band 76 can have a thickness “h” across surface 78 of about 0.2 mm, and can have a width, “w” across surface 80 from about 5 mm to about 12 mm, and more preferably, about 7 mm. It should be noted that the particular dimensions of each assembly 60, and of its components (e.g. collar 62 and its various portions, bands 76, etc.) will depend, as will be discussed later, according to particular anatomy, the desired application, and upon the particular size and configuration of the individual natural heart 10.
  • In constructing [0058] assembly 60 using bands 76, from about 2 to about 10 bands 76 may be used, and preferably about 4 bands 76 are used in the present invention. Nevertheless, the number of bands 76 may be selected dependent upon the property of the material selected for each of the bands 76, as well as the load stress required to appropriately restructure the heart chamber geometry.
  • [0059] Bands 76 are each preferably made of a light weight, generally rigid material that has a low bending strain under expected levels of stress so that the material has sufficient wear resistance in use while the heart 10 beats, and maintains its desired shape in use adjacent the heart 10. Illustrative examples of suitable materials which may be employed as bands 76 include any biocompatible or biomedical materials, such as metals, including titanium or stainless steel, or a suitable polymer, including polyacetal or an ultra high molecular weight polyethylene, or a combination of the same.
  • The [0060] collar 62 may preferably include a connector 82, and preferably a plurality of connectors 82 spaced along the collar 62, as exemplified best in FIG. 5. The connectors 82 can assist in maintaining the space relationship of the bands 76 relative to each other, and of the assembly 60 to the heart 10. Turning now to FIGS. 6-8, the connector 82 preferably has a contact or an inner surface 84, which is configured for placement adjacent or against the epicardial surface 34 of the natural heart 10. The inner surface 84 may be configured so that the epicardial surface 34 may slide along inner surface 84 during contraction and expansion of the heart 10, and to minimize damage to the epicardial surface 34, and the coronary arteries (e.g., 36). Preferably, the inner surface 84 is curved convex outwardly in a longitudinal plane (see, e.g., FIGS. 4 and 8) and has a smooth surface, and/or preferably rounded edges 87 so that collar 62 can be configured to be positioned adjacent or on the epicardial surface 34 whereby intimate contact can be established and maintained, even during the contraction or beating of the heart 10.
  • FIGS. [0061] 6-8 illustrate the connectors 82 as each including one or more grooves 92, which can extend inwardly from an opening 98 in the outer wall 86, and toward the contact or inner surface 84. Each groove 92 is preferably sized and configured to receive a band 76 whereby its surface 78 would be positioned adjacent the base wall 94, and its surfaces 80 preferably would be positioned adjacent sidewalls 96.
  • In an preferred embodiment, groove [0062] 92 should be configured to assist in allowing flexion movement of the band 76 as the heart 10 beats and moves. As best exemplified in FIGS. 6-8, grooves 92 may be tapered inwardly as the grooves 92 proceeds or extends from the outer surface 86 inwardly toward the contact surface 84. In addition, grooves 92 may also be tapered inwardly as the groove extends from each of the lateral surfaces 88 inwardly (e.g., upwardly and/or downwardly), as best illustrated in FIG. 6.
  • [0063] Connectors 82 are each preferably made of a light weight, generally rigid material that has a low bending strain under expected levels of stress so that the material has sufficient wear resistance in use while the heart 10 beats, and maintains its desired shape in use adjacent the heart 10. Illustrative examples of suitable materials which may be employed as connectors 82 may include any biocompatible or biomedical materials, such as metals, including titanium or stainless steel, or a suitable polymer, including polyacetal or an ultra high molecular weight polyethylene, or a combination of the same.
  • Turning back to FIG. 6, a [0064] structure 100 can be provided so as to assist in maintaining the bands 76 in the groove 92, in use. Any structure 100 contemplated for use with assembly 60 should assist in restricting movement of the band 76 out of the groove 92 through opening 98. In one embodiment, the structure 100 may take the form of a plate 100 that can be secured or otherwise attached, and preferably releasably secured, to close off or restrict access through one or more openings 98. In addition to a plate-like structure, sutures (not shown) may also be threaded through the connector 82 to assist in restricting bands 76 movement through opening 98. Structure 100 is preferably made of a biocompatible or biomedical material.
  • Turning now to FIGS. 11 and 12, an alternative embodiment of the present invention may include a collar or [0065] yoke 162 that provides an essentially continuous surface which contacts the epicardium surface 34 of the heart 10. In the present embodiment, collar 162 may take the form of a generally continuous yoke-like structure that is essentially rigid. Collar 162 preferably includes a contact or an inner surface 184, which is configured for placement adjacent or against the epicardial surface 34 of the natural heart 10. The inner surface 184 should be configured so that the epicardial surface 34 may slide along the inner surface 184 during contraction and expansion of the natural heart 10, and to minimize damage to the epicardial surface 34 and the coronary arteries (e.g., 36). Preferably, the inner surface 184 is curved convexly outwardly in a longitudinal plane and has a smooth surface, and/or preferably rounded edges 187 so that a collar 162 can be configured to be positioned adjacent or on the epicardial surface 34 whereby intimate contact can be established arid maintained, even during the contraction or expansion of the natural heart 10.
  • The [0066] collar 162 preferably is selected from a generally rigid biomedical or biocompatable material. Examples of such suitable materials may include a metal, such as titanium or steel, or a polymer, such as an ultra high molecular weight polyethylene, polyacetal, or a polymer composite material such as carbon fiber-epoxy or fiberglass-epoxy, or a combination of the same. Moreover, the collar 162 may be covered, either partially or entirely, with a material that promotes tissue ingrowth into the collar 162, such as a soft tissue polyester fabric sheeting or polyletrafluroethyhere (PTFE).
  • In another alternative embodiments, exemplified in FIGS. [0067] 13-14, it is contemplated that the collar 162 may include an attachment system 163 that allows the collar 162 to be placed around the heart 10, such as inbetween the pulmonary veins 30 near the basal portion of the heart 10 so as to reduce the possibility of lateral or medical displacement of the assembly 60, or about the lateral atrium or the atrioventrialar groove region. In one embodiment, the collar 162 may include an attachment system 163 that permits the collar 162 to be separated and then reattached at two or more sites or positions along the collar 162, preferably adjacent or near the region of the collar 162 configured for placement adjacent or on the basal portion and/or apical portion 20 of the natural heart 10. While the attachment system 163 is illustrated as an interlocking pin 163B and receptacle 163A (e.g., a ball and socket-likejoint), it is contemplated, and as would be appreciated by those skilled in the art, other devices and assemblies for releaseably securing the collar 162 together can be used. Example of such devices and assemblies for attachment system 163 could include sutures, a screw and bore holes through overlapping portions of the collar 162, clamps, a combination of these devices and assemblies.
  • Alternatively, as illustrated in FIG. 14, the [0068] collar 162 may include an attachment system 163 at one site along the collar 162, preferably adjacent or at the portion of the collar 162 configured for placement adjacent on or the basal portion of the heart 10. This embodiment of collar 162 preferably would include a portion 167 that can either include flexible material or a pivotable section 168 to provide movement of the collar 162 so that the attachment assembly 163 can open, and the collar 162 can be slipped around in the heart 10, and/or between the pulmonary veins 30.
  • In yet another embodiment illustrated in FIG. 15, the [0069] assembly 260 may include a collar 262 having a region 264 similar to the structure of the collar 62, exemplified above in FIGS. 4-8, and connector portions or regions 268, similar to the structure of the collar 162, discussed above, and exemplified in FIGS. 12-14.
  • To assist the [0070] epicardial surface 34 in separating from each of the collars 62, 162, or 262 adjacent or at the lateral portions 85 of inner surface 84 without creating substantial negative pressure, a pad 56 can be positioned and/or interposed between the epicardial surface 34 and the inner surface 84 of one or more of the connectors 82. Pad 56 can be, as exemplified in FIGS. 9A and 9B, a fluid-filled or gel-filled pad or cushion, which generally will occupy space laterally beyond the collar 62 and the lateral portions 85 of inner surface 84 while the heart 10 is in as a relaxed state. However, as the heart 10 contracts and the wall shortens (see, e.g., FIG. 9B), generally circumferentially (reducing cavity radius), the epicardial surface 34 will “peel away” from the collar 62 and the lateral portions 85 of inner surface 84 and thus, fluid or gel in the pads 56 can fill this space so that the inner surface 84 and epicardial surface 34 remain in contact and effect focal restraint whereby the chamber 12 is restructured, as detailed above.
  • In one embodiment, the [0071] pad 56 is a closed system. Alternatively, it is contemplated that pad 56 can be configured such that fluid and/or gel can be added or removed to enhance functionality of the device assembly of the present invention, as desired. For example, one or more lines 58 can be in fluid communication with a chamber in pad 56. Line 58 can extend from pad 56 to an injection port 59, which can be positioned subcutaneous or elsewhere, as desired, for enhanced access. As will be appreciated by those skilled in the art, fluid or gel can be injected into the injection port 59 using a standard syringe and needle, or other device, to increase the size of the pad 56 and/or the pressure within the pad 56, as desired. Alternatively, fluid or gel can be withdrawn as desired.
  • Alternatively, pad [0072] 56 can be as a low durometer polymer such as a plastic or other material (e.g., rubber). In use, as detailed above, the-material accommodates and maintains the contact between the collar 62, and more specifically its inner surface 84, and epicardial surface 34 and thus, the desired reconfiguration of the heart 10 as the heart 10 beats or deforms.
  • To assist each of the [0073] assembly 60 in remaining fixed in a spatial or spaced relationship to each other and adjacent or on the epicardial surface 34, as desired, one or more auxiliary connectors 70 is provided. Auxiliary connector 70 can take the form of various mechanical connectors used in the industry to attach and position prosthetic devices in the body.
  • [0074] Auxiliary connector 70 can take the form of a spike shaped object or pin 75 that is configured to penetrate the epicardial surface 34 into the cardiac tissue 32. Also, auxiliary connector 74 can take the form of a button 72 and cord 73. One end of the cord 73 can be attached or otherwise secured to the collar 62, and it can extend inwardly into and through the cardiac tissue 32. A button 72 can be attached to or adjacent the other end of the cord 86 adjacent the endocardial surface 38. Button 72 can be made of any biocompatible material, and is preferably made of a material that enhances tissue growth around the button 72 to minimize the possibility of the formation of blood clots. It is further contemplated that other surgical attachment articles and techniques can be used in accordance with the present invention, such as screws, surgical staples and the like, to assist in fastening and securing the assembly 60 in position, as desired.
  • Furthermore, [0075] auxiliary connector 70 can take the form of a peg 74, as exemplified in FIGS. 16-19, that can configured to be lockably received in a hole 67 positioned and/or aligned on the assembly 60, and preferably on the connectors 82 or the collar 162. Peg 74 generally comprises a generally permanent potion 74A configured preferably to be snugly received in the hole 67, as discussed above. The portion 74A can be made of any suitable biomedical or biocompatible material. Suitable examples of materials for portion 74A, can include the same materials that can be used with the collar 62, as exemplified above.
  • At the end of the [0076] portion 74A of the peg 74, a generally rigid absorbable spike 74B is provided, which preferably is a generally fustoconicall shaped and tapers inwardly as the spike 74B extends away from the portion 74A. Spike 74B is sufficiently rigid so that it can pierce the tissue and then be inserted into the muscle tissue (e.g., the cardiac tissue 32). The material used for spike 74B should be a material that is absorbable by the body tissue over a period of time. Suitable materials can include a gelatin material, which can be partially denatured thermally or chemically to control solubility and the absorption rate in the tissue (e.g., 32), a polyglycol acid, or other materials, as will be appreciated by those skilled in the industry, used with absorbable surgical devices or sutures.
  • Within the [0077] portion 74A and spike 74B is a generally flexible extension 74C configured, for example, as a strip, coil, tube, or loop which preferably may include exposed interstices (mesh), holes, loops or other surface enhancements to promote tissue in growth. Extension 74C can be made from a material to enhance tissue integration therein. Suitable examples of materials for use as extension 74C can include polyester, polypropylene, and other polymers used in as non-dissoluble implants.
  • In accordance with the teachings of the present invention, the [0078] assembly 60 should be so configured and positioned adjacent the heart 10 whereby the wall tension is reduced in accordance with LaPlace's theory of a chamber, which is as follows:
  • (Tension of wall)=K*(chamber pressure)*(radius of chamber)(wall thickness), [0079]
  • wherein K is a proportionality constant. [0080]
  • As an illustrative example of one embodiment in accordance with the teachings of the present invention, calculations will be performed based on the following model as exemplified in FIGS. 3 and 5. It is assumed that the long axis of the [0081] left ventricle 12 of the heart 10 is 100 mm, that the equatorial or short axis of the chamber 12 is 70 mm, that the equatorial wall thickness “w” of the chamber is about 10 mm and the basal diameter of the heart 10 is 60 mm. An arbitrary slice or plane of the left ventricle 12 will be analyzed to illustrate local dimensional computations for the present invention.
  • Furthermore, this model will assume that the inner radius “R[0082] 1” (of the slice or plane) of the unrestricted heart 10 (see, e.g., FIG. 3) is about 28.982 mm and that the heart 10 has an outer radius of about 38.406 mm. As is known to those skilled in the industry, the width “w” and radius “R1” can be directly obtained from high-resolution imaging, such as an echocardiogram, or preferably, by computation based on an assumed geometric model. The ratio of the restraint contract pressure of the left ventricle 12 of the device 60 to the cavity pressure can vary from 1 to about 2. This example will further assume that the allowed ratio of the restraint contact pressure of the left ventricle 12 of device 60 to the cavity pressure is to be limited to a maximum of about 1.5, which is represented by symbol K in the mathematical formulas below. Also, it is desired to achieve an altered radius “R2” of the left ventricle 12 to 80% of its original radius R1, and as such:
  • R2=0.8*R1
  • R2=0.8*28.982 mm
  • R2=23.186 mm
  • In order to calculate the radius of curvature “g” of the [0083] inner surface 64 of member 62 in the transverse plane, the following formula can be used:
  • g=(w+R2)÷(k−1)
  • g=(9.424 mm+23.186 mm)÷(1.5−1)
  • g=(32.61 mm)÷0.5
  • g=65.22 mm.
  • Now that the value of radius of curvature of the [0084] inner surface 84 “g” has been calculated, the angle “θ” between the line g1 (joining the center of curvature of the member 62 with one margin, in this plane, of the contact area between inner surface 84 and the epicardial surface 34) and line g2 (joining the same center of curvature with the center of the inner surface 84 in the same plane) can be calculated using the following formula:
  • θ=(π/2)*[R 2 −R 1]÷(R 2 +w+g)
  • θ=(π/2)*[28.982 mm −23.186 mm]÷(28.982 mm+9.424 mm+65.22 mm)
  • θ=(π/2)*[5.796 mm]÷(103.636 mm)
  • θ=0.09063 radius or 5.332 degrees
  • Using the formula below, the distance inwardly that the [0085] heart 10 should be displaced can be calculated so that the desired restructuring can be achieved. If “e” is the distance that the center of either member 62 is to be separated from the absolute center of a remodeled ventricle in this plane, then:
  • e=[(g+w+R 2)* cos θ]−g
  • e=[(65.22 mm+9.424 mm+23.186 mm)* cos 5.332 degrees]−65.22 mm
  • e=32.21 mm.
  • As such, twice e or (2*e) is 64.42 mm, and this is the preferred distance separating the oppositely disposed [0086] inner surfaces 64.
  • Based on the calculation, the wall of the [0087] heart 10 needs to be displaced or moved inwardly about 6.20 mm from the unrestrained position to achieve the desired restructure or reconfiguration whereby wall tension is adjusted, as desired. Also, using the formula 2θg to calculate the desired contacting width of the inner surface 84, which is about 11.68 mm in this example.
  • To position the [0088] assembly 60 into a body (e.g., the thoracic cavity) and around an existing natural heart 10, a high resolution image, such as a standard echocardiogram, or other analysis of the heart 10 is preferred so that certain anatomical measurements can be electronically, preferably digitally, recorded and calculated, as detailed above. While the present application only includes one set of mathematic calculations to optimize the present invention, it is contemplated that measurements will need to be taken along several axes, planes, locations or positions along the longer axis of the chamber. Pre-surgical calculations are preferred so that the assembly 60 can be constructed, as desired, before surgery to minimize surgical time, and preferably reduce or eliminate use of a heart/lung bypass machine.
  • Thoracic surgery may be required to implant [0089] assembly 60. Clinically sufficient anesthesia is administered and standard cardiac monitoring is employed to the patient and then, via a sternal or lateral wall incision, the pericardial sac where the heart 10 is usually situated is opened using standard thoracic surgical procedures, which are known to those skilled in the art.
  • Once the thoracic cavity and pericardium is opened, the [0090] heart 10 must be narrowed or constricted so that the assembly 60 can be placed around the heart 10. In one embodiment, inflow to the heart 10 may be occluded. This can be accomplished by placing a tourniquet around either the superior and/or inferior vena cava 22 and 24, respectively, as illustrated respectfully in FIGS. 1 and 2, for a brief period of time (e.g., about 3 to 4 heartbeats) whereby the heart 10 shrinks and empties. Thereafter, the collar 62 may be slipped around the heart 10. The tourniquets can be released from occlusion around the superior and/or inferior vena cavas 22 and 24, respectively, and the heart 10 re-fills with blood.
  • While for prolonged reduction of blood pressure by cardiac inflow occlusion, hypothennia techniques may be employed to lower body temperature to reduce the side effects that can be caused by reduced blood pressure in the circulatory system. [0091]
  • If an open heart procedure employed in the present invention, circulation of blood to the [0092] natural heart 10 may be bypassed so the present invention can be inserted on and/or into the patient. If so, referring back now to FIG. 2, the superior vena cava 22, the inferior vena cava 24, and aorta 26 are cannulated. The circulatory system is connected to as a cardiopulmonary bypass machine so that circulation and oxidation of the blood are maintained during the surgical procedure. By way of example, the procedure discussed in detail will be for insertion of the present invention 60 to restructure or reconfigure the left ventricle chamber 12.
  • Turning now to FIGS. [0093] 4-7 and 10, assembly 60, which may have been customized according to the anatomical measurements and calculations, is preferably positioned adjacent or against the epicardial surface 34 in predetermined locations relative to each other and relative to the chamber (e.g., left ventricle chamber 12). Assembly 60 is positioned around the heart 10 so that portions of the heart 10 are displaced or urged inwardly, as desired.
  • [0094] Auxiliary connectors 70 can be used to further secure the assembly 60 to the heart 10. Turning now to FIGS. 16-19, peg 74 can be inserted in the hole 67, whereby the spike 74B is piercing the epicardial surface 34 and is being inserted into the tissue (e.g., cardiac tissue 32). Peg 74 preferably locks into position once inserted (see FIG. 17), to further secure the assembly 60 in place. Over time, it is preferred that spike 74B, which has been inserted into the tissue, dissolve and be absorbed by the surrounding tissue. As the spike 74B is being absorbed, extension 74C becomes exposed to the tissue, and tissue thereby insinuates and grows into any exposed interstices, loops, holes, or other surface enhancements to promote tissue ingrowth. The peg 74B can thereafter be held in place by the tissue insinuation and growth into extension 74C, which can assist in maintaining the position of assembly 60.
  • Once the [0095] assembly 60 is properly positioned and secured, termination of a cardiopulmonary bypass, if used, is attempted and, if successful, the thoracotomy is closed.
  • Alternatively, once the thoracic cavity and pericardium is open, the [0096] collar 162 exemplified in FIGS. 13 and 14, can be placed around the heart 10, either between the pulmonary artery 28 and the superior left atrial surface or between the aorta and the pulmonary artery 28 and then across the posterior dorsal left atrial surface in between the left and right pulmonary veins 30. A portion of the collar 162, preferably the posterior portion, can be placed behind the heart 10. An opening is sharply and/or bluntly developed in the leaves of the pericardium forming the anterolateral margin of the oblique sinus. Then, a hemostat can be used to place a portion of the collar 162 through the opening. Alternatively, a detachable cord, with one end attached to the portion of the collar 162, can be grasped and used to pull a portion of the collar 162 through the opening. Such placement of the collar 162 across the epicardial surface 34 of the lateral atrium or atrioventricular junction should reduce the possibility of adverse medial or lateral displacement or movement of the collar 162.
  • An alternative method for positioning the present invention includes removing the [0097] natural heart 10 from the patient, positioning all the components of the present invention assembly 60, as discussed above, and auto-transplanting the natural heart 10 back into the patient using standard cardiectomy and cardiac transplant techniques known in the industry.
  • Having shown and described the preferred embodiments to the present invention, further adaptations of the activation device for the living heart as described herein can be accomplished by appropriate modifications by one of ordinary skill in the art without departing from the scope of the present invention. For example, the present invention can be used with any one or even as a plurality of the various chambers of a living heart, and also could be used with different structural embodiments to restructure he chamber. Several such potential modifications have been discussed and others will be apparent to those skilled in the art. Accordingly, the scope of the present invention should be considered in terms of the following claims and is understood not to be limited in the details, structure and operation shown and described in its specification and drawings. [0098]

Claims (26)

I claim:
1. A geometric reconfiguration assembly for a natural heart, comprising:
a collar configured for surrounding the natural heart and having a plurality of bands in a spaced relationship; and
a connector bar intersecting the plurality of bands and configured for maintaining the spaced relationship of the bands to each other.
2. The assembly of claim 1, wherein the connector bar comprises an inner surface having an outwardly convex curved configuration.
3. The assembly of claim 1, wherein each of the plurality of bands are positioned parallel to each other.
4. The assembly of claim 1, wherein the assembly comprises from about 2 to about 10 bands.
5. The assembly of claim 1, wherein the bands comprise a high strength, high modulus polymer.
6. The assembly of claim 1, wherein the bands comprise a metal.
7. The assembly of claim 1, wherein the connector bar is positioned tangential to the plurality of bands.
8. The assembly of claim 1, wherein at least one of the bands has a thickness of about 0.2 mm.
9. The assembly of claim 1, wherein each of the bands includes a thickness, and the connector bar comprises a plurality of grooves configured to receive the thickness of each of the plurality of bands.
10. The assembly of claim 9, wherein the connector bar comprises at least one beveled groove.
11. The assembly of claim 1, wherein the connector bar comprises a cushioned portion.
12. The assembly of claim 1, comprises a closure device for enclosing at least one of the bands in the connector bar.
13. The assembly of claim 1, wherein the collar comprises a first restrictor region configured to be positioned adjacent the anterolateral surface of the heart and a second restrictor region configured to be positioned adjacent posteromedial surface of the heart.
14. The assembly of claim 11, wherein the cushion portion comprises a polymeric material.
15. The assembly of claim 1, wherein said assembly comprises a pad provided adjacent the inner surface of the connector bar.
16. The assembly of claim 15, wherein the pad comprises a low durometer polymer.
17. The assembly of claim 15, wherein the pad comprises a cushion.
18. The device of claim 17, wherein the cushion comprises a gel-filled cushion.
19. The assembly of claim 17, wherein the cushion comprises a fluid-filled cushion.
20. A geometric reconfiguration assembly for a natural heart, comprising;
a collar for surrounding a portion of the natural heart, said collar having a portion configured for placement on the basal portion of the natural heart in between the left and right pulmonary veins, said collar further comprising an attachment assembly configured for releasably connecting said collar together.
21. The assembly of claim 20, wherein the collar comprises an inner surface having a outwardly convex curve configuration.
22. The assembly of claim 20, wherein the attachment system comprises a pin and receptacle, said pin and receptacle being releasably detachable.
23. A geometric reconfiguration assembly for a natural heart, comprising
a collar configured for surrounding a natural heart, said collar having a first restrictor region for placement adjacent the anterolateral surface of the heart, and a second restrictor region configured for positioning adjacent the posteromedial surface of the heart; the first and second restrictor portions each comprising a plurality of bands in a space relationship and a connector bar intersecting the plurality of band and configured for maintaining the space relationship of the bands to each other.
24. The assembly of claim 23, wherein the collar comprises a first and second connector portion configured for placement adjacent the basal portion of the heart and a second connector portion configured for a position adjacent the apical portion of the epicardium of the heart.
25. A method for reducing wall tension on one of the chambers of the heart, comprising the steps of
providing a geometric reconfiguration assembly; and
surrounding one of the chambers of the heart with a geometric configuration assembly.
26. The method of claim 25, comprising the step of occluding blood inflow into the heart prior to placement of the assembly around the chamber of the heart.
US09/834,339 1996-01-02 2001-04-13 Device and method for restructuring heart chamber geometry Abandoned US20020022880A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/834,339 US20020022880A1 (en) 1996-01-02 2001-04-13 Device and method for restructuring heart chamber geometry

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/581,914 US5957977A (en) 1996-01-02 1996-01-02 Activation device for the natural heart including internal and external support structures
US09/165,887 US6221103B1 (en) 1996-01-02 1998-09-30 Device and method for restructuring heart chamber geometry
US09/834,339 US20020022880A1 (en) 1996-01-02 2001-04-13 Device and method for restructuring heart chamber geometry

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/165,887 Continuation US6221103B1 (en) 1996-01-02 1998-09-30 Device and method for restructuring heart chamber geometry

Publications (1)

Publication Number Publication Date
US20020022880A1 true US20020022880A1 (en) 2002-02-21

Family

ID=24327080

Family Applications (3)

Application Number Title Priority Date Filing Date
US08/581,914 Expired - Fee Related US5957977A (en) 1996-01-02 1996-01-02 Activation device for the natural heart including internal and external support structures
US09/165,887 Expired - Fee Related US6221103B1 (en) 1996-01-02 1998-09-30 Device and method for restructuring heart chamber geometry
US09/834,339 Abandoned US20020022880A1 (en) 1996-01-02 2001-04-13 Device and method for restructuring heart chamber geometry

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US08/581,914 Expired - Fee Related US5957977A (en) 1996-01-02 1996-01-02 Activation device for the natural heart including internal and external support structures
US09/165,887 Expired - Fee Related US6221103B1 (en) 1996-01-02 1998-09-30 Device and method for restructuring heart chamber geometry

Country Status (7)

Country Link
US (3) US5957977A (en)
EP (2) EP1332766A3 (en)
AT (1) ATE253346T1 (en)
AU (1) AU1532597A (en)
CA (1) CA2242412C (en)
DE (1) DE69725962T2 (en)
WO (1) WO1997024101A1 (en)

Cited By (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010018611A1 (en) * 1999-06-30 2001-08-30 Solem Jan Otto Method and device for treatment of mitral insufficiency
US20020019580A1 (en) * 2000-03-10 2002-02-14 Lilip Lau Expandable cardiac harness for treating congestive heart failure
US20020077524A1 (en) * 1997-01-02 2002-06-20 Myocor, Inc. Heart wall tension reduction apparatus
US20020151961A1 (en) * 2000-01-31 2002-10-17 Lashinski Randall T. Medical system and method for remodeling an extravascular tissue structure
US20020169359A1 (en) * 1997-01-02 2002-11-14 Myocor, Inc. Methods and devices for improving cardiac function in hearts
US20030050529A1 (en) * 2000-03-21 2003-03-13 Myocor, Inc. Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly
US20030135267A1 (en) * 2002-01-11 2003-07-17 Solem Jan Otto Delayed memory device
US20030153949A1 (en) * 2001-10-31 2003-08-14 Lilip Lau Heart failure treatment device and method
US6612978B2 (en) 1999-12-22 2003-09-02 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
US20030181928A1 (en) * 2000-10-06 2003-09-25 Myocor, Inc. Endovascular splinting devices and methods
US20030233022A1 (en) * 2002-06-12 2003-12-18 Vidlund Robert M. Devices and methods for heart valve treatment
US20040039443A1 (en) * 1999-06-30 2004-02-26 Solem Jan Otto Method and device for treatment of mitral insufficiency
US20040055608A1 (en) * 1993-02-22 2004-03-25 Ethicon, Inc. Minimally-invasive devices and methods for treatment of congestive heart failure
US6723038B1 (en) 2000-10-06 2004-04-20 Myocor, Inc. Methods and devices for improving mitral valve function
US20040102841A1 (en) * 2000-01-31 2004-05-27 Langberg Jonathan J. Percutaneous mitral annuloplasty with cardiac rhythm management
US6746471B2 (en) 1998-07-29 2004-06-08 Myocor, Inc. Transventricular implant tools and devices
US20040127983A1 (en) * 1997-12-17 2004-07-01 Myocor, Inc. Valve to myocardium tension members device and method
US20040133220A1 (en) * 2000-01-31 2004-07-08 Randall Lashinski Adjustable transluminal annuloplasty system
US6764510B2 (en) 2002-01-09 2004-07-20 Myocor, Inc. Devices and methods for heart valve treatment
US20040143156A1 (en) * 2001-09-10 2004-07-22 Lilip Lau Device for treating heart failure
US20040148019A1 (en) * 2002-11-12 2004-07-29 Vidlund Robert M. Devices and methods for heart valve treatment
US20040148020A1 (en) * 2002-11-12 2004-07-29 Vidlund Robert M. Devices and methods for heart valve treatment
US6802319B2 (en) 1993-02-22 2004-10-12 John H. Stevens Minimally-invasive devices and methods for treatment of congestive heart failure
US20040210104A1 (en) * 2002-11-15 2004-10-21 Lilip Lau Cardiac harness delivery device and method
US6808488B2 (en) 1998-09-21 2004-10-26 Myocor, Inc. External stress reduction device and method
US20040249242A1 (en) * 2003-03-28 2004-12-09 Lilip Lau Multi-panel cardiac harness
US20040254600A1 (en) * 2003-02-26 2004-12-16 David Zarbatany Methods and devices for endovascular mitral valve correction from the left coronary sinus
US20050043792A1 (en) * 1999-06-29 2005-02-24 Edwards Lifesciences Ag Device and method for treatment of mitral insufficiency
US20050054892A1 (en) * 2003-07-10 2005-03-10 Lilip Lau Self-anchoring cardiac harness
US20050059855A1 (en) * 2002-11-15 2005-03-17 Lilip Lau Cardiac harness delivery device and method
US20050080483A1 (en) * 2001-12-28 2005-04-14 Solem Jan Otto Delayed memory device
US20050085903A1 (en) * 2003-10-17 2005-04-21 Jan Lau Heart valve leaflet locator
US20050096740A1 (en) * 2001-01-30 2005-05-05 Edwards Lifesciences Ag Transluminal mitral annuloplasty
US20050102012A1 (en) * 2003-11-07 2005-05-12 Lilip Lau Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing
US20050102013A1 (en) * 2003-11-07 2005-05-12 Lilip Lau Cardiac harness for treating heart disease
US20050137673A1 (en) * 2003-11-07 2005-06-23 Lilip Lau Cardiac harness having electrodes and epicardial leads
US20050154253A1 (en) * 2004-01-12 2005-07-14 Lilip Lau Cardiac harness having interconnected strands
US20050171589A1 (en) * 2003-11-07 2005-08-04 Lilip Lau Cardiac harness and method of delivery by minimally invasive access
US20050177228A1 (en) * 2003-12-16 2005-08-11 Solem Jan O. Device for changing the shape of the mitral annulus
US20050222678A1 (en) * 2004-04-05 2005-10-06 Lashinski Randall T Remotely adjustable coronary sinus implant
US20050256368A1 (en) * 2002-11-15 2005-11-17 Paracor Medical, Inc. Introducer for a cardiac harness delivery
US20050283042A1 (en) * 2003-03-28 2005-12-22 Steve Meyer Cardiac harness having radiopaque coating and method of use
US20060009675A1 (en) * 2004-07-08 2006-01-12 Steven Meyer Self-anchoring cardiac harness for treating the heart and for defibrillating and/or pacing/sensing
US20060129026A1 (en) * 2004-12-15 2006-06-15 Joshua Wallin Apparatus and method for mounting a cardiac harness on the heart
US20060129051A1 (en) * 2004-12-09 2006-06-15 Rowe Stanton J Diagnostic kit to assist with heart valve annulus adjustment
US20060247491A1 (en) * 2005-04-27 2006-11-02 Vidlund Robert M Devices and methods for heart valve treatment
US20070027516A1 (en) * 2005-08-01 2007-02-01 Alan Schaer Cardiac harness having an optimal impedance range
US20070032696A1 (en) * 2005-07-22 2007-02-08 Sieu Duong Cardiac harness delivery device
US20070055091A1 (en) * 2004-12-02 2007-03-08 Lilip Lau Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing
US20070106336A1 (en) * 2003-11-07 2007-05-10 Alan Schaer Cardiac harness assembly for treating congestive heart failure and for pacing/sensing
US20070106359A1 (en) * 2003-11-07 2007-05-10 Alan Schaer Cardiac harness assembly for treating congestive heart failure and for pacing/sensing
US20070129598A1 (en) * 2001-09-07 2007-06-07 Raman Jaishanker Method and apparatus for external stabilization of the heart
US20070255093A1 (en) * 2002-11-15 2007-11-01 Lilip Lau Cardiac harness delivery device and method
US20070287883A1 (en) * 2006-06-07 2007-12-13 Lilip Lau Apparatus and method for pulling a cardiac harness onto a heart
US20090048480A1 (en) * 2007-08-13 2009-02-19 Paracor Medical, Inc. Cardiac harness delivery device
US20090156892A1 (en) * 2002-09-05 2009-06-18 Paracor Medical, Inc. Cardiac harness
US20090281372A1 (en) * 2008-05-06 2009-11-12 Paracor Medical, Inc. Cardiac harness assembly for treating congestive heart failure and for defibrillation and/or pacing/sensing
US7695512B2 (en) 2000-01-31 2010-04-13 Edwards Lifesciences Ag Remotely activated mitral annuloplasty system and methods
US20100274076A1 (en) * 1997-01-02 2010-10-28 Edwards Lifesciences Llc Heart Wall Tension Reduction Apparatus and Method
US20100298935A1 (en) * 2007-09-12 2010-11-25 Surgical Energetics, Inc. Medical Device and Tension Member for Use in a Subject
US20110004053A1 (en) * 2007-12-05 2011-01-06 Surgical Energetics, Inc. bolster for securing a septal splint to a cardiac wall, a method of use thereof, and a system including the same
US7976454B2 (en) 2002-01-07 2011-07-12 Paracor Medical, Inc. Cardiac harness
US8192351B2 (en) 2007-08-13 2012-06-05 Paracor Medical, Inc. Medical device delivery system having integrated introducer
US8439817B2 (en) 1998-07-29 2013-05-14 Edwards Lifesciences, Llc Chordae capturing methods for stress reduction
US9375218B2 (en) 2006-05-03 2016-06-28 Datascope Corp. Systems and methods of tissue closure
US10485545B2 (en) 2013-11-19 2019-11-26 Datascope Corp. Fastener applicator with interlock
US11653928B2 (en) 2018-03-28 2023-05-23 Datascope Corp. Device for atrial appendage exclusion

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592619B2 (en) 1996-01-02 2003-07-15 University Of Cincinnati Heart wall actuation device for the natural heart
US6520904B1 (en) * 1996-01-02 2003-02-18 The University Of Cincinnati Device and method for restructuring heart chamber geometry
US20030045771A1 (en) * 1997-01-02 2003-03-06 Schweich Cyril J. Heart wall tension reduction devices and methods
US6045497A (en) 1997-01-02 2000-04-04 Myocor, Inc. Heart wall tension reduction apparatus and method
US6610004B2 (en) * 1997-10-09 2003-08-26 Orqis Medical Corporation Implantable heart assist system and method of applying same
US6889082B2 (en) * 1997-10-09 2005-05-03 Orqis Medical Corporation Implantable heart assist system and method of applying same
US6190408B1 (en) * 1998-03-05 2001-02-20 The University Of Cincinnati Device and method for restructuring the heart chamber geometry
US6733510B1 (en) 1999-01-12 2004-05-11 University Of Cincinnati Article and method for coupling muscle to a prosthetic device
US6110100A (en) * 1998-04-22 2000-08-29 Scimed Life Systems, Inc. System for stress relieving the heart muscle and for controlling heart function
US6685627B2 (en) 1998-10-09 2004-02-03 Swaminathan Jayaraman Modification of properties and geometry of heart tissue to influence heart function
US8715156B2 (en) * 1998-10-09 2014-05-06 Swaminathan Jayaraman Modification of properties and geometry of heart tissue to influence function
US6695768B1 (en) 1999-03-30 2004-02-24 Robert A. Levine Adjustable periventricular ring/ring like device/method for control of ischemic mitral regurgitation and congestive heart disease
CN1376082A (en) * 1999-09-24 2002-10-23 博士伦公司 Process for purifying and reusing solvent used to remove extractables
EP1294305A2 (en) 2000-05-31 2003-03-26 Cardioclasp, Inc. Devices and methods for assisting natural heart function
US20030023132A1 (en) * 2000-05-31 2003-01-30 Melvin David B. Cyclic device for restructuring heart chamber geometry
US20050113798A1 (en) * 2000-07-21 2005-05-26 Slater Charles R. Methods and apparatus for treating the interior of a blood vessel
US6343605B1 (en) 2000-08-08 2002-02-05 Scimed Life Systems, Inc. Percutaneous transluminal myocardial implantation device and method
US6846296B1 (en) 2000-09-14 2005-01-25 Abiomed, Inc. Apparatus and method for detachably securing a device to a natural heart
US6572534B1 (en) 2000-09-14 2003-06-03 Abiomed, Inc. System and method for implanting a cardiac wrap
US6808483B1 (en) * 2000-10-03 2004-10-26 Paul A. Spence Implantable heart assist devices and methods
US6602182B1 (en) 2000-11-28 2003-08-05 Abiomed, Inc. Cardiac assistance systems having multiple fluid plenums
US6540659B1 (en) 2000-11-28 2003-04-01 Abiomed, Inc. Cardiac assistance systems having bi-directional pumping elements
US6547716B1 (en) * 2000-11-28 2003-04-15 Abiomed, Inc. Passive cardiac restraint systems having multiple layers of inflatable elements
US6616596B1 (en) 2000-11-28 2003-09-09 Abiomed, Inc. Cardiac assistance systems having multiple layers of inflatable elements
US6810882B2 (en) 2001-01-30 2004-11-02 Ev3 Santa Rosa, Inc. Transluminal mitral annuloplasty
US6702763B2 (en) * 2001-02-28 2004-03-09 Chase Medical, L.P. Sizing apparatus and method for use during ventricular restoration
US20030181940A1 (en) * 2001-02-28 2003-09-25 Gregory Murphy Ventricular restoration shaping apparatus and method of use
US6622730B2 (en) 2001-03-30 2003-09-23 Myocor, Inc. Device for marking and aligning positions on the heart
US7311731B2 (en) * 2001-04-27 2007-12-25 Richard C. Satterfield Prevention of myocardial infarction induced ventricular expansion and remodeling
US20020188170A1 (en) * 2001-04-27 2002-12-12 Santamore William P. Prevention of myocardial infarction induced ventricular expansion and remodeling
US6626821B1 (en) 2001-05-22 2003-09-30 Abiomed, Inc. Flow-balanced cardiac wrap
US20040243170A1 (en) * 2001-09-05 2004-12-02 Mitta Suresh Method and device for percutaneous surgical ventricular repair
US7485088B2 (en) * 2001-09-05 2009-02-03 Chase Medical L.P. Method and device for percutaneous surgical ventricular repair
US7174896B1 (en) 2002-01-07 2007-02-13 Paracor Medical, Inc. Method and apparatus for supporting a heart
WO2003061486A1 (en) * 2002-01-23 2003-07-31 Iotek, Inc. Devices for holding a body organ
US20030139645A1 (en) * 2002-01-23 2003-07-24 Adelman Thomas G. Rotational freedom for a body organ
US6951533B2 (en) * 2002-02-04 2005-10-04 Iotek, Inc. Organ manipulation assistance during surgical procedure
US20030212456A1 (en) * 2002-05-09 2003-11-13 John Lipchitz Implant for tissue repair
US7081084B2 (en) * 2002-07-16 2006-07-25 University Of Cincinnati Modular power system and method for a heart wall actuation system for the natural heart
US20040059180A1 (en) * 2002-09-23 2004-03-25 The University Of Cincinnati Basal mounting cushion frame component to facilitate extrinsic heart wall actuation
US7850729B2 (en) * 2002-07-18 2010-12-14 The University Of Cincinnati Deforming jacket for a heart actuation device
US20040015041A1 (en) * 2002-07-18 2004-01-22 The University Of Cincinnati Protective sheath apparatus and method for use with a heart wall actuation system for the natural heart
US20040015040A1 (en) * 2002-07-18 2004-01-22 The University Of Cincinnati Flexible, torsionable cardiac framework for heart wall actuation of the natural heart
US6988982B2 (en) * 2002-08-19 2006-01-24 Cardioenergetics Heart wall actuation system for the natural heart with shape limiting elements
US7341584B1 (en) 2003-05-30 2008-03-11 Thomas David Starkey Device and method to limit filling of the heart
WO2004110553A1 (en) 2003-06-09 2004-12-23 The University Of Cincinnati Actuation mechanisms for a heart actuation device
WO2004110257A2 (en) 2003-06-09 2004-12-23 The University Of Cincinnati Power system for a heart actuation device
US20060178551A1 (en) * 2003-06-09 2006-08-10 Melvin David B Securement system for a heart actuation device
US7513867B2 (en) * 2003-07-16 2009-04-07 Kardium, Inc. Methods and devices for altering blood flow through the left ventricle
AU2003904283A0 (en) * 2003-08-12 2003-08-28 Northern Sydney Area Health Service An implantable direct cardiac compression device and system
US20050085683A1 (en) * 2003-10-15 2005-04-21 Bolling Steven F. Implantable heart assist system and method of applying same
US7056286B2 (en) 2003-11-12 2006-06-06 Adrian Ravenscroft Medical device anchor and delivery system
EP1708655A1 (en) * 2003-12-09 2006-10-11 GI Dynamics, Inc. Apparatus to be anchored within the gastrointestinal tract and anchoring method
US20050131385A1 (en) * 2003-12-12 2005-06-16 Bolling Steven F. Cannulae for selectively enhancing blood flow
WO2005079388A2 (en) * 2004-02-13 2005-09-01 The University Of Cincinnati A coupling device enabled by mechanical continuity of cellular scaffolding across tissue boundaries
US8206439B2 (en) * 2004-02-23 2012-06-26 International Heart Institute Of Montana Foundation Internal prosthesis for reconstruction of cardiac geometry
US20050277870A1 (en) * 2004-06-10 2005-12-15 Robert Pecor Cannula having reduced flow resistance
US7445592B2 (en) * 2004-06-10 2008-11-04 Orqis Medical Corporation Cannulae having reduced flow resistance
US8753392B2 (en) 2005-01-07 2014-06-17 University Of Cincinnati Elements for versatility of a prosthetic anchor
WO2006074413A2 (en) * 2005-01-07 2006-07-13 University Of Cincinnati Prosthetic anchor and method of making same
CN1804714B (en) * 2005-01-12 2011-08-03 佳能株式会社 Optical device
US20060184199A1 (en) * 2005-02-14 2006-08-17 O'leary Shawn Apparatus and methods for reducing bleeding from a cannulation site
US20060224110A1 (en) * 2005-03-17 2006-10-05 Scott Michael J Methods for minimally invasive vascular access
US7715918B2 (en) * 2005-10-18 2010-05-11 University Of Cincinnati Muscle energy converter with smooth continuous tissue interface
US7749249B2 (en) * 2006-02-21 2010-07-06 Kardium Inc. Method and device for closing holes in tissue
US20070208217A1 (en) 2006-03-03 2007-09-06 Acorn Cardiovascular, Inc. Self-adjusting attachment structure for a cardiac support device
CA2677968C (en) 2006-05-15 2014-07-08 Enovacor Aps A system and a method for altering the geometry of the heart
US8449605B2 (en) 2006-06-28 2013-05-28 Kardium Inc. Method for anchoring a mitral valve
US8075471B2 (en) * 2006-07-12 2011-12-13 Allegheny-Singer Research Institute Apical torsion device for cardiac assist
US7837610B2 (en) * 2006-08-02 2010-11-23 Kardium Inc. System for improving diastolic dysfunction
US8529620B2 (en) 2007-05-01 2013-09-10 Ottavio Alfieri Inwardly-bowed tricuspid annuloplasty ring
US8092363B2 (en) 2007-09-05 2012-01-10 Mardil, Inc. Heart band with fillable chambers to modify heart valve function
US20090076597A1 (en) * 2007-09-19 2009-03-19 Jonathan Micheal Dahlgren System for mechanical adjustment of medical implants
US20090287304A1 (en) 2008-05-13 2009-11-19 Kardium Inc. Medical Device for Constricting Tissue or a Bodily Orifice, for example a mitral valve
WO2011041571A2 (en) 2009-10-01 2011-04-07 Kardium Inc. Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valve
US10092427B2 (en) 2009-11-04 2018-10-09 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US9649211B2 (en) 2009-11-04 2017-05-16 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US9107749B2 (en) 2010-02-03 2015-08-18 Edwards Lifesciences Corporation Methods for treating a heart
SE535140C2 (en) 2010-03-25 2012-04-24 Jan Otto Solem An implantable device, kit and system for improving cardiac function, including means for generating longitudinal movement of the mitral valve
US9050066B2 (en) 2010-06-07 2015-06-09 Kardium Inc. Closing openings in anatomical tissue
US8940002B2 (en) 2010-09-30 2015-01-27 Kardium Inc. Tissue anchor system
US8932350B2 (en) 2010-11-30 2015-01-13 Edwards Lifesciences Corporation Reduced dehiscence annuloplasty ring
US9072511B2 (en) 2011-03-25 2015-07-07 Kardium Inc. Medical kit for constricting tissue or a bodily orifice, for example, a mitral valve
EP2906151B1 (en) 2012-10-12 2023-06-21 Mardil, Inc. Cardiac treatment system
USD717954S1 (en) 2013-10-14 2014-11-18 Mardil, Inc. Heart treatment device
WO2016133203A1 (en) * 2015-02-19 2016-08-25 学校法人久留米大学 Ventricular assistance device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5702343A (en) * 1996-10-02 1997-12-30 Acorn Medical, Inc. Cardiac reinforcement device
US6206820B1 (en) * 1995-10-18 2001-03-27 Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung Device for supporting cardiac function having elastic filling chambers
US6332893B1 (en) * 1997-12-17 2001-12-25 Myocor, Inc. Valve to myocardium tension members device and method

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2826193A (en) * 1956-08-01 1958-03-11 Vineberg Heart Foundation Cardiac resuscitation device
US3053249A (en) * 1959-08-25 1962-09-11 Gorman Rupp Ind Inc Cardiac massage apparatus
FR92798E (en) * 1966-09-05 1968-12-27 Rhone Poulenc Sa New cardiac assistance prosthesis and its manufacture.
US3455298A (en) * 1967-04-10 1969-07-15 George L Anstadt Instrument for direct mechanical cardiac massage
US3590815A (en) * 1969-01-07 1971-07-06 Peter Shiff Portable mechanical ventricular assistance device
US3613672A (en) * 1969-07-09 1971-10-19 Peter Schiff Mechanical ventricular assistance cup
US3668708A (en) * 1969-12-23 1972-06-13 North American Rockwell Artificial heart
FR2083989A5 (en) * 1970-03-02 1971-12-17 Cabezudo Jose
US3827426A (en) * 1971-07-16 1974-08-06 P Sawyer Prosthetic pump
US3983863A (en) * 1975-06-02 1976-10-05 American Hospital Supply Corporation Heart support for coronary artery surgery
US4192293A (en) * 1978-09-05 1980-03-11 Manfred Asrican Cardiac assist device
US4621617A (en) * 1981-06-29 1986-11-11 Sharma Devendra N Electro-magnetically controlled artificial heart device for compressing cardiac muscle
IT1155105B (en) * 1982-03-03 1987-01-21 Roberto Parravicini PLANT DEVICE TO SUPPORT THE MYOCARDIUM ACTIVITY
US4535483A (en) * 1983-01-17 1985-08-20 Hemex, Inc. Suture rings for heart valves
SU1191076A1 (en) * 1984-01-04 1985-11-15 Институт Механики Полимеров Ан Латвсср Heart valve frame
US4690134A (en) * 1985-07-01 1987-09-01 Snyders Robert V Ventricular assist device
FR2591489B1 (en) * 1985-12-16 1988-03-25 Aerospatiale TOTAL HEART PROSTHESIS COMPRISING TWO PUMPING MODULES CONNECTED BY A FUNCTIONAL LINK.
SE454942B (en) 1986-05-22 1988-06-13 Astra Tech Ab HEART HELP DEVICE FOR INOPERATION IN BROSTHALAN
SU1604377A1 (en) 1987-02-23 1990-11-07 Благовещенский государственный медицинский институт Artificial pericardium
US4925443A (en) 1987-02-27 1990-05-15 Heilman Marlin S Biocompatible ventricular assist and arrhythmia control device
US4809676A (en) * 1987-12-28 1989-03-07 Freeman Maynard L Heart assist device and method of implanting it
US4846831A (en) * 1988-04-27 1989-07-11 Skillin David E Manual back-up drive for artificial heart
US5139517A (en) * 1989-11-08 1992-08-18 Corral David F Orthotopic intraventricular heart pump
US5358519A (en) * 1989-12-06 1994-10-25 Medtronic, Inc. Muscle control and monitoring system
US5131905A (en) * 1990-07-16 1992-07-21 Grooters Ronald K External cardiac assist device
US5119804A (en) * 1990-11-19 1992-06-09 Anstadt George L Heart massage apparatus
US5109843A (en) * 1990-11-30 1992-05-05 University Of Cincinnati Extra to-intracorporeal power supply
US5169381A (en) 1991-03-29 1992-12-08 Snyders Robert V Ventricular assist device
US5370685A (en) * 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
US5192314A (en) 1991-12-12 1993-03-09 Daskalakis Michael K Synthetic intraventricular implants and method of inserting
JP3393383B2 (en) * 1992-01-21 2003-04-07 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Septal defect closure device
US5258021A (en) * 1992-01-27 1993-11-02 Duran Carlos G Sigmoid valve annuloplasty ring
US5201880A (en) * 1992-01-27 1993-04-13 Pioneering Technologies, Inc. Mitral and tricuspid annuloplasty rings
US5383840A (en) * 1992-07-28 1995-01-24 Vascor, Inc. Biocompatible ventricular assist and arrhythmia control device including cardiac compression band-stay-pad assembly
WO1994003142A1 (en) 1992-07-30 1994-02-17 Temple University - Of The Commonwealth System Of Higher Education Direct manual cardiac compression device and method of use thereof
US5256132A (en) * 1992-08-17 1993-10-26 Snyders Robert V Cardiac assist envelope for endoscopic application
US5345949A (en) 1992-09-02 1994-09-13 Shlain Leonard M Methods for use in surgical gastroplastic procedure
US5571176A (en) * 1993-04-02 1996-11-05 Taheri; Syde A. Partially autogenous four chambered heart
US5385528A (en) * 1993-06-17 1995-01-31 Wilk; Peter J. Intrapericardial assist device and associated method
US5533958A (en) * 1993-06-17 1996-07-09 Wilk; Peter J. Intrapericardial assist device and associated method
US5487760A (en) * 1994-03-08 1996-01-30 Ats Medical, Inc. Heart valve prosthesis incorporating electronic sensing, monitoring and/or pacing circuitry
US5593424A (en) 1994-08-10 1997-01-14 Segmed, Inc. Apparatus and method for reducing and stabilizing the circumference of a vascular structure
US5738627A (en) * 1994-08-18 1998-04-14 Duke University Bi-ventricular cardiac assist device
US5713954A (en) * 1995-06-13 1998-02-03 Abiomed R&D, Inc. Extra cardiac ventricular assist device
US5800528A (en) * 1995-06-13 1998-09-01 Abiomed R & D, Inc. Passive girdle for heart ventricle for therapeutic aid to patients having ventricular dilatation
US5749883A (en) 1995-08-30 1998-05-12 Halpern; David Marcos Medical instrument
US5738626A (en) * 1996-06-14 1998-04-14 Jarvik; Robert Two-step cardiomyoplasty with ventricular reduction
US6077214A (en) 1998-07-29 2000-06-20 Myocor, Inc. Stress reduction apparatus and method
US6045497A (en) 1997-01-02 2000-04-04 Myocor, Inc. Heart wall tension reduction apparatus and method
US6183411B1 (en) 1998-09-21 2001-02-06 Myocor, Inc. External stress reduction device and method
US5961440A (en) * 1997-01-02 1999-10-05 Myocor, Inc. Heart wall tension reduction apparatus and method
US6050936A (en) 1997-01-02 2000-04-18 Myocor, Inc. Heart wall tension reduction apparatus
US6019722A (en) * 1997-09-17 2000-02-01 Guidant Corporation Device to permit offpump beating heart coronary bypass surgery
US6110100A (en) 1998-04-22 2000-08-29 Scimed Life Systems, Inc. System for stress relieving the heart muscle and for controlling heart function
AU745832B2 (en) 1998-07-13 2002-04-11 Acorn Cardiovascular, Inc. Cardiac disease treatment device and method
US6260552B1 (en) 1998-07-29 2001-07-17 Myocor, Inc. Transventricular implant tools and devices

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6206820B1 (en) * 1995-10-18 2001-03-27 Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung Device for supporting cardiac function having elastic filling chambers
US5702343A (en) * 1996-10-02 1997-12-30 Acorn Medical, Inc. Cardiac reinforcement device
US6332893B1 (en) * 1997-12-17 2001-12-25 Myocor, Inc. Valve to myocardium tension members device and method

Cited By (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080029105A1 (en) * 1993-02-22 2008-02-07 Ethicon, Inc. Minimally-invasive devices and methods for treatment of congestive heart failure
US7213601B2 (en) 1993-02-22 2007-05-08 Heartport, Inc Minimally-invasive devices and methods for treatment of congestive heart failure
US20040055608A1 (en) * 1993-02-22 2004-03-25 Ethicon, Inc. Minimally-invasive devices and methods for treatment of congestive heart failure
US6802319B2 (en) 1993-02-22 2004-10-12 John H. Stevens Minimally-invasive devices and methods for treatment of congestive heart failure
US20090137863A1 (en) * 1997-01-02 2009-05-28 Myocor, Inc. Heart wall tension reduction apparatus
US7695425B2 (en) 1997-01-02 2010-04-13 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
US20100274076A1 (en) * 1997-01-02 2010-10-28 Edwards Lifesciences Llc Heart Wall Tension Reduction Apparatus and Method
US8267852B2 (en) 1997-01-02 2012-09-18 Edwards Lifesciences, Llc Heart wall tension reduction apparatus and method
US6755777B2 (en) 1997-01-02 2004-06-29 Myocor, Inc. Heart wall tension reduction apparatus and method
US20060161040A1 (en) * 1997-01-02 2006-07-20 Myocor, Inc. Methods and devices for improving cardiac function in hearts
US20040167374A1 (en) * 1997-01-02 2004-08-26 Myocor, Inc. Heart wall tension reduction apparatus and method
US20020169359A1 (en) * 1997-01-02 2002-11-14 Myocor, Inc. Methods and devices for improving cardiac function in hearts
US20020077524A1 (en) * 1997-01-02 2002-06-20 Myocor, Inc. Heart wall tension reduction apparatus
US6793618B2 (en) 1997-01-02 2004-09-21 Myocor, Inc. Heart wall tension reduction apparatus
US7883539B2 (en) 1997-01-02 2011-02-08 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
US8460173B2 (en) 1997-01-02 2013-06-11 Edwards Lifesciences, Llc Heart wall tension reduction apparatus and method
US8226711B2 (en) 1997-12-17 2012-07-24 Edwards Lifesciences, Llc Valve to myocardium tension members device and method
US8187323B2 (en) 1997-12-17 2012-05-29 Edwards Lifesciences, Llc Valve to myocardium tension members device and method
US20060052868A1 (en) * 1997-12-17 2006-03-09 Myocor, Inc. Valve to myocardium tension members device and method
US20060195012A1 (en) * 1997-12-17 2006-08-31 Myocor, Inc. Valve to myocardium tension members device and method
US20040127983A1 (en) * 1997-12-17 2004-07-01 Myocor, Inc. Valve to myocardium tension members device and method
US7981020B2 (en) 1998-07-29 2011-07-19 Edwards Lifesciences Llc Transventricular implant tools and devices
US20080319256A1 (en) * 1998-07-29 2008-12-25 Myocor, Inc. Transventricular implant tools and devices
US7722523B2 (en) 1998-07-29 2010-05-25 Edwards Lifesciences Llc Transventricular implant tools and devices
US6746471B2 (en) 1998-07-29 2004-06-08 Myocor, Inc. Transventricular implant tools and devices
US8439817B2 (en) 1998-07-29 2013-05-14 Edwards Lifesciences, Llc Chordae capturing methods for stress reduction
US20050148815A1 (en) * 1998-07-29 2005-07-07 Myocor, Inc. Transventricular implant tools and devices
US6808488B2 (en) 1998-09-21 2004-10-26 Myocor, Inc. External stress reduction device and method
US8579798B2 (en) 1998-09-21 2013-11-12 Edwards Lifesciences, Llc External cardiac stress reduction method
US20050065396A1 (en) * 1998-09-21 2005-03-24 Myocor, Inc. External stress reduction device and method
US7044967B1 (en) 1999-06-29 2006-05-16 Edwards Lifesciences Ag Device and method for treatment of mitral insufficiency
US7311728B2 (en) 1999-06-29 2007-12-25 Edwards Lifesciences Ag Device and method for treatment of mitral insufficiency
US20050043792A1 (en) * 1999-06-29 2005-02-24 Edwards Lifesciences Ag Device and method for treatment of mitral insufficiency
US6997951B2 (en) 1999-06-30 2006-02-14 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
US7192442B2 (en) 1999-06-30 2007-03-20 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
US20040039443A1 (en) * 1999-06-30 2004-02-26 Solem Jan Otto Method and device for treatment of mitral insufficiency
US8709074B2 (en) 1999-06-30 2014-04-29 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
US7090695B2 (en) 1999-06-30 2006-08-15 Edwards Lifesciences Ag Method for treatment of mitral insufficiency
US20030069636A1 (en) * 1999-06-30 2003-04-10 Solem Jan Otto Method for treatment of mitral insufficiency
US20040102840A1 (en) * 1999-06-30 2004-05-27 Solem Jan Otto Method and device for treatment of mitral insufficiency
US20010018611A1 (en) * 1999-06-30 2001-08-30 Solem Jan Otto Method and device for treatment of mitral insufficiency
US6702732B1 (en) 1999-12-22 2004-03-09 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
US6612978B2 (en) 1999-12-22 2003-09-02 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
US6663558B2 (en) 1999-12-23 2003-12-16 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
US20040102841A1 (en) * 2000-01-31 2004-05-27 Langberg Jonathan J. Percutaneous mitral annuloplasty with cardiac rhythm management
US20040138744A1 (en) * 2000-01-31 2004-07-15 Randall Lashinski Transluminal mitral annuloplasty with active anchoring
US7935146B2 (en) 2000-01-31 2011-05-03 Edwards Lifesciences Ag Percutaneous mitral annuloplasty with hemodynamic monitoring
US20110009957A1 (en) * 2000-01-31 2011-01-13 Edwards Lifesciences Ag Percutaneous mitral annulplasty with cardiac rhythm management
US20020151961A1 (en) * 2000-01-31 2002-10-17 Lashinski Randall T. Medical system and method for remodeling an extravascular tissue structure
US20040133220A1 (en) * 2000-01-31 2004-07-08 Randall Lashinski Adjustable transluminal annuloplasty system
US20040176840A1 (en) * 2000-01-31 2004-09-09 Langberg Jonathan J. Percutaneous mitral annuloplasty with hemodynamic monitoring
US7695512B2 (en) 2000-01-31 2010-04-13 Edwards Lifesciences Ag Remotely activated mitral annuloplasty system and methods
US20040153146A1 (en) * 2000-01-31 2004-08-05 Randall Lashinski Methods and apparatus for remodeling an extravascular tissue structure
US7988726B2 (en) 2000-01-31 2011-08-02 Edward Lifesciences Llc Percutaneous mitral annuloplasty with cardiac rhythm management
US6595912B2 (en) 2000-03-10 2003-07-22 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
US20030065248A1 (en) * 2000-03-10 2003-04-03 Lilip Lau Cardiac treatment apparatus
US6682474B2 (en) 2000-03-10 2004-01-27 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
US20020019580A1 (en) * 2000-03-10 2002-02-14 Lilip Lau Expandable cardiac harness for treating congestive heart failure
US20050020874A1 (en) * 2000-03-10 2005-01-27 Lilip Lau Expandable cardiac harness for treating congestive heart failure
US6602184B2 (en) 2000-03-10 2003-08-05 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
US6612979B2 (en) 2000-03-10 2003-09-02 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
US20030050529A1 (en) * 2000-03-21 2003-03-13 Myocor, Inc. Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly
US20060149123A1 (en) * 2000-03-21 2006-07-06 Myocor, Inc. Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly
US20050075723A1 (en) * 2000-10-06 2005-04-07 Myocor, Inc. Methods and devices for improving mitral valve function
US7766812B2 (en) 2000-10-06 2010-08-03 Edwards Lifesciences Llc Methods and devices for improving mitral valve function
US6723038B1 (en) 2000-10-06 2004-04-20 Myocor, Inc. Methods and devices for improving mitral valve function
US20060241340A1 (en) * 2000-10-06 2006-10-26 Myocor, Inc. Methods and devices for improving mitral valve function
US20030181928A1 (en) * 2000-10-06 2003-09-25 Myocor, Inc. Endovascular splinting devices and methods
US9198757B2 (en) 2000-10-06 2015-12-01 Edwards Lifesciences, Llc Methods and devices for improving mitral valve function
US20090270980A1 (en) * 2000-10-06 2009-10-29 Edwards Lifesciences Llc Methods and Devices for Improving Mitral Valve Function
US20050096740A1 (en) * 2001-01-30 2005-05-05 Edwards Lifesciences Ag Transluminal mitral annuloplasty
US9289298B2 (en) 2001-09-07 2016-03-22 Mardil, Inc. Method and apparatus for external stabilization of the heart
US20080215074A1 (en) * 2001-09-07 2008-09-04 Raman Jaishankar Method and apparatus for external stabilization of the heart
US8715160B2 (en) 2001-09-07 2014-05-06 Mardil, Inc. Method and apparatus for external stabilization of the heart
US8092367B2 (en) 2001-09-07 2012-01-10 Mardil, Inc. Method for external stabilization of the base of the heart
US8128553B2 (en) 2001-09-07 2012-03-06 Mardil, Inc. Method and apparatus for external stabilization of the heart
US20070129598A1 (en) * 2001-09-07 2007-06-07 Raman Jaishanker Method and apparatus for external stabilization of the heart
US20040143156A1 (en) * 2001-09-10 2004-07-22 Lilip Lau Device for treating heart failure
US20050014992A1 (en) * 2001-09-10 2005-01-20 Lau Lilip Device for treating heart failure
US20030153949A1 (en) * 2001-10-31 2003-08-14 Lilip Lau Heart failure treatment device and method
US20050033109A1 (en) * 2001-10-31 2005-02-10 Lilip Lau Heart failure treatment device and method
US8075616B2 (en) 2001-12-28 2011-12-13 Edwards Lifesciences Ag Apparatus for applying a compressive load on body tissue
US20050080483A1 (en) * 2001-12-28 2005-04-14 Solem Jan Otto Delayed memory device
US7976454B2 (en) 2002-01-07 2011-07-12 Paracor Medical, Inc. Cardiac harness
US20100185276A1 (en) * 2002-01-09 2010-07-22 Edwards Lifesciences Llc Devices and Methods for Heart Valve Treatment
US8070805B2 (en) 2002-01-09 2011-12-06 Edwards Lifesciences Llc Devices and methods for heart valve treatment
US20060041306A1 (en) * 2002-01-09 2006-02-23 Myocor, Inc. Devices and methods for heart valve treatment
US7678145B2 (en) 2002-01-09 2010-03-16 Edwards Lifesciences Llc Devices and methods for heart valve treatment
US6764510B2 (en) 2002-01-09 2004-07-20 Myocor, Inc. Devices and methods for heart valve treatment
US8506624B2 (en) 2002-01-09 2013-08-13 Edwards Lifesciences, Llc Devices and methods for heart valve treatment
US7192443B2 (en) 2002-01-11 2007-03-20 Edwards Lifesciences Ag Delayed memory device
US20030135267A1 (en) * 2002-01-11 2003-07-17 Solem Jan Otto Delayed memory device
US20030233022A1 (en) * 2002-06-12 2003-12-18 Vidlund Robert M. Devices and methods for heart valve treatment
US20090156892A1 (en) * 2002-09-05 2009-06-18 Paracor Medical, Inc. Cardiac harness
US20040148020A1 (en) * 2002-11-12 2004-07-29 Vidlund Robert M. Devices and methods for heart valve treatment
US7666224B2 (en) 2002-11-12 2010-02-23 Edwards Lifesciences Llc Devices and methods for heart valve treatment
US20040148019A1 (en) * 2002-11-12 2004-07-29 Vidlund Robert M. Devices and methods for heart valve treatment
US20050033322A1 (en) * 2002-11-15 2005-02-10 Lilip Lau Cardiac harness delivery device and method
US7736299B2 (en) 2002-11-15 2010-06-15 Paracor Medical, Inc. Introducer for a cardiac harness delivery
US20040210104A1 (en) * 2002-11-15 2004-10-21 Lilip Lau Cardiac harness delivery device and method
US20050256368A1 (en) * 2002-11-15 2005-11-17 Paracor Medical, Inc. Introducer for a cardiac harness delivery
US20070255093A1 (en) * 2002-11-15 2007-11-01 Lilip Lau Cardiac harness delivery device and method
US20050055032A1 (en) * 2002-11-15 2005-03-10 Lilip Lau Cardiac harness delivery device and method
US20050059855A1 (en) * 2002-11-15 2005-03-17 Lilip Lau Cardiac harness delivery device and method
US20040254600A1 (en) * 2003-02-26 2004-12-16 David Zarbatany Methods and devices for endovascular mitral valve correction from the left coronary sinus
US20040249242A1 (en) * 2003-03-28 2004-12-09 Lilip Lau Multi-panel cardiac harness
US20050283042A1 (en) * 2003-03-28 2005-12-22 Steve Meyer Cardiac harness having radiopaque coating and method of use
US20050054892A1 (en) * 2003-07-10 2005-03-10 Lilip Lau Self-anchoring cardiac harness
US7004176B2 (en) 2003-10-17 2006-02-28 Edwards Lifesciences Ag Heart valve leaflet locator
US20050085903A1 (en) * 2003-10-17 2005-04-21 Jan Lau Heart valve leaflet locator
US20050171589A1 (en) * 2003-11-07 2005-08-04 Lilip Lau Cardiac harness and method of delivery by minimally invasive access
US20050137673A1 (en) * 2003-11-07 2005-06-23 Lilip Lau Cardiac harness having electrodes and epicardial leads
US20070055310A1 (en) * 2003-11-07 2007-03-08 Lilip Lau Cardiac harness for treating heart disease
US20050102012A1 (en) * 2003-11-07 2005-05-12 Lilip Lau Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing
US20070112390A1 (en) * 2003-11-07 2007-05-17 Lilip Lau Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing
US20090043152A1 (en) * 2003-11-07 2009-02-12 Paracor Medical, Inc. Delivery device for cardiac harness
US20070106359A1 (en) * 2003-11-07 2007-05-10 Alan Schaer Cardiac harness assembly for treating congestive heart failure and for pacing/sensing
US20070106336A1 (en) * 2003-11-07 2007-05-10 Alan Schaer Cardiac harness assembly for treating congestive heart failure and for pacing/sensing
US20050102010A1 (en) * 2003-11-07 2005-05-12 Lilip Lau Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing
US20050102013A1 (en) * 2003-11-07 2005-05-12 Lilip Lau Cardiac harness for treating heart disease
US20050119717A1 (en) * 2003-11-07 2005-06-02 Lilip Lau Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing
US20050177228A1 (en) * 2003-12-16 2005-08-11 Solem Jan O. Device for changing the shape of the mitral annulus
US20080027274A1 (en) * 2004-01-12 2008-01-31 Paracor Medical, Inc. Cardiac harness having interconnected strands
US20050154253A1 (en) * 2004-01-12 2005-07-14 Lilip Lau Cardiac harness having interconnected strands
US7993397B2 (en) 2004-04-05 2011-08-09 Edwards Lifesciences Ag Remotely adjustable coronary sinus implant
US20050222678A1 (en) * 2004-04-05 2005-10-06 Lashinski Randall T Remotely adjustable coronary sinus implant
US20060009675A1 (en) * 2004-07-08 2006-01-12 Steven Meyer Self-anchoring cardiac harness for treating the heart and for defibrillating and/or pacing/sensing
US20070055091A1 (en) * 2004-12-02 2007-03-08 Lilip Lau Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing
US7806928B2 (en) 2004-12-09 2010-10-05 Edwards Lifesciences Corporation Diagnostic kit to assist with heart valve annulus adjustment
US20060129051A1 (en) * 2004-12-09 2006-06-15 Rowe Stanton J Diagnostic kit to assist with heart valve annulus adjustment
US20070168023A1 (en) * 2004-12-09 2007-07-19 Rowe Stanton J Diagnostic kit to assist with heart valve annulus adjustment
US20060129026A1 (en) * 2004-12-15 2006-06-15 Joshua Wallin Apparatus and method for mounting a cardiac harness on the heart
US20060247491A1 (en) * 2005-04-27 2006-11-02 Vidlund Robert M Devices and methods for heart valve treatment
US20070032696A1 (en) * 2005-07-22 2007-02-08 Sieu Duong Cardiac harness delivery device
US20070027516A1 (en) * 2005-08-01 2007-02-01 Alan Schaer Cardiac harness having an optimal impedance range
US9375218B2 (en) 2006-05-03 2016-06-28 Datascope Corp. Systems and methods of tissue closure
US10595861B2 (en) 2006-05-03 2020-03-24 Datascope Corp. Systems and methods of tissue closure
US11369374B2 (en) 2006-05-03 2022-06-28 Datascope Corp. Systems and methods of tissue closure
US20070287883A1 (en) * 2006-06-07 2007-12-13 Lilip Lau Apparatus and method for pulling a cardiac harness onto a heart
US20090048480A1 (en) * 2007-08-13 2009-02-19 Paracor Medical, Inc. Cardiac harness delivery device
US8192351B2 (en) 2007-08-13 2012-06-05 Paracor Medical, Inc. Medical device delivery system having integrated introducer
US20100298935A1 (en) * 2007-09-12 2010-11-25 Surgical Energetics, Inc. Medical Device and Tension Member for Use in a Subject
US9492270B2 (en) 2007-09-12 2016-11-15 Alan Joel Melvin Medical device and tension member for use in a subject
US20110004053A1 (en) * 2007-12-05 2011-01-06 Surgical Energetics, Inc. bolster for securing a septal splint to a cardiac wall, a method of use thereof, and a system including the same
US20090281372A1 (en) * 2008-05-06 2009-11-12 Paracor Medical, Inc. Cardiac harness assembly for treating congestive heart failure and for defibrillation and/or pacing/sensing
US10485545B2 (en) 2013-11-19 2019-11-26 Datascope Corp. Fastener applicator with interlock
US11564689B2 (en) 2013-11-19 2023-01-31 Datascope Corp. Fastener applicator with interlock
US11653928B2 (en) 2018-03-28 2023-05-23 Datascope Corp. Device for atrial appendage exclusion

Also Published As

Publication number Publication date
WO1997024101A1 (en) 1997-07-10
EP1332766A2 (en) 2003-08-06
ATE253346T1 (en) 2003-11-15
CA2242412C (en) 2002-04-30
EP0874614A1 (en) 1998-11-04
DE69725962T2 (en) 2004-05-06
DE69725962D1 (en) 2003-12-11
CA2242412A1 (en) 1997-07-10
US5957977A (en) 1999-09-28
EP1332766A3 (en) 2004-01-07
AU1532597A (en) 1997-07-28
US6221103B1 (en) 2001-04-24
EP0874614B1 (en) 2003-11-05

Similar Documents

Publication Publication Date Title
US6221103B1 (en) Device and method for restructuring heart chamber geometry
US6520904B1 (en) Device and method for restructuring heart chamber geometry
US6190408B1 (en) Device and method for restructuring the heart chamber geometry
US7361191B2 (en) Heart wall actuation device for the natural heart
US6179791B1 (en) Device for heart measurement
US6572533B1 (en) Cardiac disease treatment and device
US6896652B2 (en) Cardiac disease treatment and device
EP1638627B1 (en) Device for proactive modulation of cardiac strain patterns
US20030023132A1 (en) Cyclic device for restructuring heart chamber geometry
US20040059180A1 (en) Basal mounting cushion frame component to facilitate extrinsic heart wall actuation
JP2022540406A (en) Cardiac chamber prostheses and related cardiac assist systems

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION